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CHAPTER 1:  
Introduction 
 
1.1 Epilepsy and epilepsy surgery 
An epileptic seizure is defined as a transient occurrence of signs and/or symptoms 
due to abnormal excessive or synchronous neuronal activity in the brain. Epilepsy is 
characterized by the occurrence of multiple unprovoked epileptic seizures (“at least 2 
unprovoked or reflex seizures >24 hours apart” (Fisher 2014)). The addition of the 
criterion “multiple”  is essential, as although epilepsy is a common brain disorder with 
an estimated prevalence of 0.4 to 1.4% (WHO 2015), non-febrile seizures anywhere 
during lifetime are estimated to occur in 2-6% of the population (Research Committee 
1960, Annegers 1979, Goodridge 1983, Juul-Jensen 1983). However, this definition 
is too limited to reflect present insights and current knowledge. Therefor, in the 
present operational clinical definition of epilepsy described in the same article (Fisher 
2014), “diagnosis of an epilepsy syndrome” is incorporated:  “one unprovoked (or 
reflex) seizure and a probability of further seizures similar to the general recurrence 
risk (at least 60%) after two unprovoked seizures, occurring over the next 10 years”. 
In order to predict a recurrence rate after a first seizure,  a routine EEG is registered 
and often an EEG after sleep deprivation. Donselaar et al (1990) demonstrated that 2 
years after a first unprovoked seizure the recurrence rate of seizures in untreated 
patients was 83% if epileptiform discharges (like interictal spikes and sharp waves) 
were present in routine-EEG or EEG after sleep deprivation. If both EEG’s were 
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completely normal, the recurrence rate was 12%. Specificity of the combined EEG’s 
was 91%. Stroink et al (1998) described a seizure recurrence rate of 71% in children 
in the first two years after a first seizure when epileptiform abnormalities were present 
on their EEG.  Concluding, EEG is very helpful in predicting recurrence of seizures, 
but EEG’s without abnormalities do not rule out the existence of epilepsy.  
Finding a lesion on brain imaging can also indicate a higher chance of seizures 
recurrencing. In adults presenting on the emergency ward with a first seizure 
presence of an abnormality on CT scan had a positive predictive value of 78% for 
developing epilepsy (Sierra-Marcos et al 2011). Arthur et al (2008) demonstrated that 
in children the presence of a significant abnormality on MRI leads to a recurrence 
rate of 80%, with all first recurrences within 9 months. However, in a review that 
same year Pohlmann-Eden and Newton (2011) still conclude that “there is a striking 
lack of systematic studies using early EEG and MRI in order to better characterize 
epileptogenic areas and elucidate the mechanisms of seizure provocation”. In 2011 
Gaillard et al mention “the lack of high quality data reflecting fundamental 
weaknesses in many imaging studies but also limitations in the assumptions 
underlying evidence classification schemes”. For MRI, however, there are numerous 
reports on patients in epilepsy surgery literature with “epileptogenic lesions”, e.g. 
focal cortical dysplasia, DNET, cerebral infarct or bleeding, hamartoma, tumor, 
etcetera, thus highlighting the importance of MRI to demonstrate a possible 
underlying structural cause of epilepsy. 
On the other side of the spectrum, it has been estimated that between 10 and 30% of 
patients referred to epilepsy centers have paroxysmal events that despite looking like 
epileptic episodes are in fact non-epileptic (Auxéméry 2011). There seems to be a 
trend that faster referral to a tertiairy center is more likely in the PNES (Psychogenic 
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Non-Epileptic Seizures)-group with more profound psychological complaints (Bodde 
2012). Further improvement in differentiating and diagnosing epilepsy and non-
epileptic fits would be beneficial in guiding treatment. 
Once epilepsy is diagnosed, it has to be classified in order to guide further treatment. 
“With the avalanche of genetic, structural, and functional information, it has become 
abundantly evident that what we call the epilepsies are really complex neurological 
and even multisystem disorders that may involve cognitive, behavioral, motor, sleep, 
autonomic, and other systemic impairments and dysfunctions. Seizures are a facet, 
often a prominent one, of these disorders, but seizures are not disorders unto 
themselves“ (Berg 2016). This more detailed approach will help in investigating and 
understanding the different causes of epilepsy and to further tailor treatment. 
However, although finer classification is possible (Berg 2010), the major impact for 
the purpose of this thesis stems from the division between localization related 
epilepsy and the others. Although not advocated as the descriptions of first choice, 
Berg and Scheffer (2011) acknowledge that the term localization related epilepsy 
may still apply in some circumstances. Most of the surgically treatable epilepsies will 
be denominated structural.  
Once the epilepsy has been classified, treatment with anti epileptic drugs can be 
started. As epilepsy in adults in most cases is a chronic condition, life long treatment 
is often necessary (Brodie 2012, Burakgazi 2016). In children, however, in 60% 
epilepsy is a transient condition, for which medication given over a limited number of 
years is sufficient. There is a negative correlation to age of onset of epilepsy, 
meaning that a negative prognostic factor to achieve complete remission (seizure 
and drug free) is an age of onset of over 10 years of age (Berg 2014). This is in line 
with the reviews of Beghi (2015) and of Walsh (2016) claiming that “most epilepsies 
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have a good prognosis for full seizure control and eventual discontinuation of AEDs”, 
while the history of a high number of seizures at the time of diagnosis, intellectual 
disability, and symptomatic aetiology are negative predictors (for long-term 
prognosis)”. However, in about 41% of newly diagnosed epilepsy patients, even with 
medication sustained seizure freedom is not reached according to Brodie (2012). The 
epilepsy will thus prove to be drug-resistant, also called refractory. In these patients 
with refractory epilepsy non-idiopathic epilepsy is about 3 to 4 times as prevalent as 
idiopathic  epilepsy (according to modern terminology epilepsy of genetic or 
metabolic origin) (Brodie 2012). In those patients, epilepsy surgery must be 
considered. A Cochrane review showed that good post-operative outcome, over-all 
being 65%, ranges from 13,5% to 92.5% (West 2015), depending on duration of 
follow up, location of the epileptogenic focus, extend of the (possible) resection, used 
technique and underlying pathology. According to a Swedish cohort study, if a 
surgically removable focus can be found chances of post operative seizure freedom 
over the long term is about 62 % in adults and 50% in children (Edelvik 2013). In a 
review in 2015, Hu et al calculated a pooled post-operative seizure freedom in 73% 
of the operated patients. In patients with localization related epilepsy originating in 
the temporal lobe surgery is significantly better than drug therapy in improving quality 
of life (Fiest 2014). All together, surgery is the best available option for these patients. 
Therefor, it is worthwhile to put as much effort as possible in identifying good surgical 
candidates and targets. 
In pre-surgical analysis, several definitions are used to clarify what is analysed 
exactly. The irritative zone (Talairach 1966) is defined as the region of cortex that 
generates interictal epileptiform discharges in the EEG or MEG (Lüders and Awad 
1992). The epileptogenic zone is defined as the region of cortex that can generate 
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epileptic seizures. By definition, total removal or disconnection of the epileptogenic 
zone is necessary and sufficient for seizure freedom. These regions, however, do not 
necessary coincide with the seizure onset zone (the region where the clinical 
seizures originate), the ictal symptomatogenic zone (the region of cortex that 
generates the initial seizure symptoms), the functional deficit zone (the region of 
cortex that in the interictal period is functionally abnormal, as indicated by 
neurological examination, neuropsychological testing and functional imaging or non-
epileptiform EEG or MEG abnormalities) or even the epileptogenic lesion (the 
structural lesion that is causally related to the epilepsy) (Lüders and Awad 1992). For 
this analysis, a thorough pre-surgical evaluation is necessary. The evaluation 
includes video-EEG seizure recordings (with simultaneous recording of semiology 
and ictal EEG-findings), state-of-the-art MRI, neuropsychologic testing and on 
indication PET, (f)MEG, SPECT, EEG-fMRI, fMRI, DTI, TCD, TMS, visual field 
analysis, intracranial recordings and testing, etcetera. Which tests are used is 
dependent on indication, availability and necessity. Throughout Europe there is no 
uniformity in the pre-surgical protocol (e.g. Mouthaan 2016).    
One of the major factors in predicting successful epilepsy surgery is finding a 
structural lesion that corresponds with the other electro-clinical data (West 2015). At 
1.5T, MRI provides images that show abnormalities that could account for the 
epilepsy in up to 83% of the patients with localization-related epilepsy within a pre-
surgical evaluation (Ubach 2004). However, in a more recent study on 158 operated 
patients with frontal lobe epilepsy, of which 76% were lesional cases as seen on 1.5T 
or 3T MRI, only 44% were postoperatively seizure-free (Simasathien et al. 2013). 
Failure to reach seizure freedom in this group can partly be attributed to incomplete 
resection when the lesion/focus is too close to eloquent cortex. However, in many 
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cases (like in dysplastic lesions) the epileptogenic focus may not necessarily overlap 
completely with the visible structural anomaly. Furthermore, it is postulated that many 
of the “MRI-negative” patients actually suffer from Focal Cortical Dysplasia (FCD) 
(Bautista 2003). A Cleveland Clinic analysis of 95 operated  “MRI-negative” epilepsy 
patients found FCD (in majority type I) at histopathology in 45% of cases (Wang 
2013). FCD is highly associated with refractory epilepsy (Guerinni 2014). In formerly 
MRI-negative patients, re-evaluation of the MRI with all available data will show more 
abnormalities. Of the operated patients, in 22% of bottom-of-the-sulcus FCD’s the 
lesion can be missed on initial visual inspection of the MRI (Harvey 2015). Gain of 
MRI could be improved by improving scanning techniques (including higher field 
strength, Von Oertzen 2002) and by predefining a region of interest. Clinical 
symptoms of the seizures are strong localizers and reasonably strong lateralizers for 
the epileptogenic zone whereas ictal EEG is strongly lateralizing and reasonably 
localizing (Kotagal 2010). If MEG results are compatible with a plausible location of a 
possible epileptogenic zone they are also powerful indicators for the region of interest 
(Bagic 2016).  
 
1.2 MEG 
 
MEG is a non-invasive method to record brain activity, with a history in humans  
dating back to 1968 (Cohen 1968). Changes in the pericranial magnetic field, 
generated by the electrical currents in the brain, are measured. In order to be able to 
record these changes, which are of the magnitude of pico-Tesla, recordings must 
take place in a magnetically shielded room, using highly cooled super-conductant 
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sensors (SQUIDS (superconducting quantum interference devices), gradiometers or 
magnetometers). In contrast to EEG which depends mostly on the radial component 
of the electric currents produced by the neurons, MEG is mainly dependent on the 
tangential component. However, source depth, and not orientation, is the main factor 
that compromises the sensitivity of MEG to activity in the adult human cortex  
(Hillebrand 2002). At the convexity, about 3 to 4 cm2 of synchronous active cortex 
produces a detectable MEG-signal, as compared to 6-10 cm2 needed for a 
detectable EEG signal (Cooper 1965, Oishi 2002, Tao 2006). In analysing possible 
epilepsy patients interictal epileptiform discharges in the MEG, like spikes and spike-
waves, support the diagnosis of epilepsy (this thesis). 
If epileptiform discharges are recorded, in order to facilitate interpretation of MEG 
data for clinical use an attempt can be made to estimate its source. The results of 
source estimations (often equivalent current dipole (ECD) solutions) can be projected 
on the MRI of the same patient. This is called Magnetic Source Imaging (MSI) 
(Williamson 1991). MSI is a valuable tool in the presurgical work-up (Bagic 2016). 
The mathematical exercise to calculate the source of a given spike starts from the 
presumption that the recorded activity originates from one single source or at most a 
very limited number of sources (the inverse problem). The most likely solution of the 
equations at hand will be the one best explaining most of the recorded signal. If no 
dipole can explain at least 70% of the signal, the solution is too weak to accept. 
Despite these caveats, there is a good correlation between recording of spikes and 
their location as measured simultaneously with Acute CorticoGraphy (ACoG) and 
MEG (Oishi 2002). One has to keep in mind that interictal sharp MEG-activity merely 
indicates the irritative zone, but not always the epileptogenic zone as well. Over the 
years MEG has proven to be a very powerful tool to determine the epileptogenic zone 
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or the irritative zone in patients who have enough spikes in their traces (e.g. 
Ossenblok 1999, Shiraishi 2001, Van ‘t Ent 2003, Iida 2005, Papanicolaou 2005, 
Ossenblok 2007). Higher ECD-clustering in a specific area correlates with a higher 
likelihood of indicating the seizure onset zone ( Mamelak 2002). In non-lesional 
epilepsy surgery, MEG-source localization has proven to be of value to guide 
implantation of intracranial electrodes (Brodbeck 2011, Heers 2012). Complete 
removal of the area with clustered ECD’s leads to better outcome of epilepsy surgery 
and vise versa (Widjaja 2008, Wilenius 2013). 
 
1.3 MRI 
MRI is an imaging method based on Nuclear Magnetic Resonance (NMR). It is a 
non-invasive method using quantum mechanical properties of nuclei with an uneven 
number of protons to make images of structures and acquire information on the 
concentration of different molecular compounds. Applying the Bloch-equations, it is 
possible to describe the obtained reactions based on quantum mechanical principles 
with the more simple mechanical laws of physics. When a human body is submitted 
to the strong magnetic field of the MRI-scanner the tissues, like brain, acquire a small 
amount of measurable magnetism. Each type of tissue (e.g. white or grey matter) has 
different magnetic properties which can be shown in an image by applying property-
specific radio-frequency pulses (RF) for contrast and time-varying magnetic gradients 
for localization. By changing the time sequence of successive RF pulses and their 
properties (e.g. duration, frequency, bandwidth), different tissue contrasts can be 
obtained. The most important iconic contrasts in MRI are T1 and T2 contrasts. 
Images depicting those contrasts are better know as T1- and T2-weighted images 
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(T1W, T2W). Other contrasts are related to other properties, like proton density 
and diffusion. The amount of signal that can be obtained is a complex function of the 
field strength. Generally the Signal-to-Noise-Ratio (SNR) in the images scales 
linearly with the field strength of the scanner. This is important for this thesis because 
imaging of epilepsy patients at a very high field strength of 7T is reported. 
The beauty of MRI is that basic contrasts can be manipulated to accentuate certain 
tissues. FLAIR for example is such a manipulated T2W image, where the normal high 
water signal is suppressed, resulting in an improvement of the detection of FCD’s. 
Several investigations emphasise that the gain of MRI in epilepsy patients can be 
enhanced by specific procedures. Not only, for example, are conventional low field 
strength MRI studies inferior to higher field strength studies such as 3T MRI (Winston 
2013), but also the experience of the neuroradiologist plays an important role (Von 
Oertzen 2002). Scanning protocol, including slice-orientation can also play an 
important role (Meiners 1997).   
For more extensive description of the MRI technology, several handbooks are 
available, e.g. Magnetic Resonance in Epilepsy, 2005 by Kuzniecky and Jackson and 
Neuroradiology: the requisites, 2010 by Zimmerman et al. Also recommended are the 
following articles: Bloch 1946, Purcell 1946, Hahn 1950, Bloch 1953, Purcell 1953, 
Vleck 1970, Lauterbur 1973, Mansfield 1977, Buxton 1987. 
The theoretical basis of Nuclear Magnetic Resonance (NMR, the basis of MRI) was 
provided in 1924 by Wolfgang Pauli in mail correspondence with colleagues, 
demonstrating hyperfine splitting in atomic spectra and concluding that many nuclei 
possess both a magnetic moment and an angular momentum. In 1946 almost 
simultaneously both at Harvard and at Stanford University NMR phenomena were 
described by respectively Purcell and Bloch. Both showed how electromagnetic 
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waves could flip atomic nuclei that were aligned in a static magnetic field. Initially, this 
technique was used by physicists and chemists. In 1973, Lauterbur described how 
operator-controlled magnetic field gradients could be used to encode position-
dependent information in the NMR signal. This suggested the possibility of 
generating cross-sectional anatomic images of human beings. The first reports of 
MRI used to acquire images in live human subjects were made in 1976 (Mansfield) 
and 1977 (Damadian). Major technical developments, like improvements on the coils, 
more elaborated sequences but also application of higher magnetic field strength, 
ameliorated the quality of the obtained images. Providing images with ever improving 
contrast resolution, MRI quickly became the gold standard in imaging in epilepsy 
patients. The first report on epilepsy patients with gliomas that were not seen on CT 
but detected with MRI was published in 1984 (Aaron). Focal cortical dysplasia is 
described on MRI in 1987 (Sellier). However, even with the present achievements, 
MRI will not show abnormalities in a substantial proportion of epilepsy patients. For 
example, MRI showed no abnormalities in over 40% of children with newly diagnosed 
epilepsy in a cohort of 259 subjects with (presumed) symptomatic focal epilepsy 
(Vecchi 2016). 
 
1.4 MRS 
Specific other MRI techniques have also been applied in epilepsy patients. One of 
them is Magnetic Resonance Spectroscopy (MRS), picturing metabolic compound 
concentrations, like N-acetylaspartate (NAA), choline (Cho) and Creatin (Cr), in the 
brain. For these compounds, 1H MRS is used. In different chemical compounds local 
magnetic field is influenced differently in function of the organization of the electrons 
surrounding the hydrogen proton. Their number and resulting relative electrode cloud 
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are different for different molecules, leading to different changes in local magnetic 
field. In response to the external B0 electrons move to oppose this magnetic field, 
thus shielding the nucleus. In order to get the same local magnetic field, and thus 
resonance at the same frequency, the magnitude of B0 therefor has to be increased. 
This increase is molecule-dependent and typically only a fraction of the original B0. 
The change needed is expressed in ppm (parts-per-million): the percentage of 
change compared to the original B0 to obtain a resonance multiplied by 10,000. In 
order to get reliable results, extra care has to be taken to make B0 as homogeneous 
as possible. This can be achieved by “shimming”, an automated process in most 
MRS-sequences. 
 As each type of molecule has a different change, a spectrum can be recorded. For 
the brain, this spectrum for 1H-containing molecules is narrow: it spans a band of 
about 12 ppm. The H2O peak is high, compared to the other components; the 
concentration of H2O exceeds the concentration of the metabolites that are of 
interest by a factor 10,000+. Therefor, water suppression techniques are applied. 
After correcting for this H2O peak, NAA, Cho and Cr peaks are reasonably easy to 
distinguish. Myo-inositol (Ins), GABA and Glutamate are less easy to distinguish and 
require a shorter TE.  
 The intensity of the signal is linearly proportional to the number of 1H atoms at that 
specific magnetic field/resonance in the sample. A molecule with double the amount 
of hydrogen will therefor show a double magnitude on the spectrum as compared to 
the low hydrogen molecule if concentrations are equal 
(https://www2.chemistry.msu.edu/faculty/reusch/virttxtjml/spectrpy/nmr/nmr1.htm). 
Concentrations are usually expressed as ratio’s to Cr, as presence of Cr is 
reasonably stable throughout the brain. It is a marker for brain energy metabolism 
20 
 
(Rubaek Danielsen 1999). It is also possible to use absolute values but this is 
technically much more challenging (Janssen 2006). 
NAA concentrations increase during maturation (Rubaek Danielsen 1999). Local 
decrease of NAA concentration is associated with neuronal loss and neuronal 
damage (Castillo 1996, Burtscher 2001). 
Choline and choline containing compounds are markers of cell membrane turn-over. 
Increase of choline concentration is associated with tumors and with demyelination 
(Maheshwari 2000). 
We used single voxel MRS (SV-MRS), where relative concentrations in a limited 
volume (the “voxel”)  are determined. This is a time-efficient procedure with a 
relatively high SNR, partly due to the smaller volume that has to be shimmed. 
Alternative techniques are 2D-Chemical Shift Imaging (CSI) and 3D-CSI. These 
techniques require longer scanning times and have a lower SNR (Vigneron 2001, 
Janssen 2006),  
 
1.5 MEG-guided MRI 
Three studies highlight the importance of ROI guided MRI-analysis (Moore 2002, 
Funke 2011, Itabashi 2014). Summarizing, all find a gain of MEG-guided MRI re-
evaluation of 20% in those MRI’s that were deemed to be normal before adding the 
MEG-information. No report of MEG-guided analysis of 7T MRI is available up to 
now. 
 
21 
 
1.6 SEEG  
 
SEEG or Stereo-EEG is an intracranial EEG recording with multiple depth electrodes 
placed within the brain. Based on the work of Penfield and Jasper (1954) and the 
development of stereotactic devices (Spiegel 1947) the method was further 
developed and advocated by Talairach and Bancaud (Bancaud 1959, Talairach 
1973). First, after the non-invasive pre-surgical analysis hypotheses are formulated 
about the epileptogenic zone and the spreading pattern. Guided by these hypotheses 
and based on an MRI with double dose of contrast to visualize the blood vessels to 
avoid, multiple depth electrodes with several contact points each are stereotactically 
placed within the brain. The electrodes are inserted through small burr holes 
(typically up to 2.3 mm in diameter) and fixated to the skull.  After this surgical 
procedure, the patient will be transferred to the epilepsy monitoring unit (EMU). 
Subsequent recording of intracerebral EEG combined with video will take place to 
determine the seizure onset zone. Time spend on the EMU varies in function of the 
number of clinically different seizure types, seizure frequency and response to 
electrostimulation. SEEG allows for the recording of intracerebral EEG, thus reaching 
areas that cannot be sampled by subdural grids and/or strips. Also in the case of 
wide-spread hypotheses, SEEG has an advantage over subdural grids due to 
technical limitations of the latter (Lhatoo 2016).  
Electrostimulation is a procedure where a current of several milli-amperes is 
delivered between two adjacent contact points, thus focally hampering brain function. 
This allows functional mapping in the regions where electrodes are placed, thereby 
giving the neurosurgeon an indication of the functional (eloquent) areas. Secondly, 
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stimulation is used to try to provoke seizures or part of the seizures, thus giving 
additional insight in the location of the epileptogenic zone and of the spreading 
pattern. For mapping purposes, on average subdural grids are more suited than 
SEEG. 
When sufficient information is gathered the electrodes are removed and the data 
analyzed. If the epileptogenic zone can be identified and is not located within 
eloquent cortex, resection will follow several months later. 
Compared to subdural recording (Wellmer 2012), SEEG is a relatively safe 
procedure. Complication rates of  2.4 to 4.5% (Guenot 2001, Almeida 2006, 
Cardinale 2015, González-Martínez 2016) have been reported. Reported 
complication rate, however is also dependent on the used definition of complications. 
In our own limited series on our first 23 SEEG implantations (Colon 2014) we 
reported a complication rate of 13% when including irritation of the skin at the 
entrance point of one of the electrodes. Looking at long lasting neurological deficit, 
only one patient (4%) experienced an aggravation of his pre-implantation already 
present afasia after subdural haemorrhage due to the implantation. This resolved 
spontaneously within 8 months. No other long lasting neurological deficits were 
noted. 
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CHAPTER 2:  
Aim and outline of this thesis 
 
This thesis is conceptualized having a patient in mind that comes to a tertiary 
epilepsy center after having tried several anti-epileptic drugs without any positive 
result. In such a case, the first question to resolve is whether or not the diagnosis of 
epilepsy is correct. If this is the case the next question is whether or not this patient is 
a candidate for epilepsy surgery, making of utmost importance not only the correct 
diagnosis, but also a correct lateralisation and localization of the epileptigenic zone 
and eloquent cortex (the what and the where). Diagnostic procedures are 
continuously developing, and the researches presented in this thesis are part of that 
development. Emphasis is put on those investigations that utilize magnetic fields. 
Therefor, the aim of this thesis is to investigate possible ameliorations of diagnostics 
in epilepsy, both in first line, e.i. diagnosing epilepsy, as in localizing the 
epileptogenic zone in case of presurgical analysis. The studies in this thesis examine 
possible roles for MEG and MRI in improving diagnostics in epilepsy, both alone and 
in combination. 
The two articles that are comprised in chapter 3 describe the validity of MEG in 
diagnosing epilepsy; in the first article as compared to EEG after sleep deprivation, in 
the second article as compared to the long term diagnosis. Results in these patients 
are partly used to define the region of interest in the patients of chapter 4. 
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The three articles that are comprised in Chapter 4 describe MEG-guided single voxel 
magnetic MRS at 3 Tesla and MEG guided 7 Tesla MRI support in localizing an 
epileptogenic zone or lesion in epilepsy patients. As the most frequent “missed 
abnormalities” in MRI negative epilepsy patients probably are FCD’s (Bautista 2003, 
Wang 2013), prior to the study on MEG guided 7T MRI in 3T MRI negative patients 
an analysis is made of patients with known FCD to get an impression of the 
appearance of FCD on 7T MRI. 
Chapter 5 is a synopsis of the conclusions formulated in the prior chapters. 
Chapter 6 represents a more open interpretation of the impact on clinical practice in a 
tertiary epilepsy center of the studies described in chapters 3 and 4.  
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CHAPTER 3: 
MEG in diagnosing Epilepsy 
3.1 MEG in primary diagnostics 
26 
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Use of Routine MEG in the Primary Diagnostic 
Process of Epilepsy 
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Abstract: Purpose: At present, in epilepsy magnetoencephalography (MEG) is 
mostly used for pre-surgical evaluations. It has proven to be robust for detecting and 
localizing inter-ictal epileptiform discharges. Whether this is also true for first line 
investigation in the diagnosis of epilepsy has not yet been investigated. We present 
our data on the usefulness of MEG in the earliest phase of diagnosing epilepsy.  
Methods: We examined 51 patients with suspicion of neocortical epilepsy and an 
inconclusive routine EEG. A method to integrate MEG in daily routine was developed.  
Results of visually assessed MEG recordings were compared, retrospectively, with 
clinical data and with results of EEG after sleep deprivation.  
Results: After a negative routine EEG, routine MEG generated a gain in diagnostic 
value of 63 % as compared to “final” clinical diagnosis. This is comparable with the 
added value of EEG after sleep deprivation recorded previously in the same patients. 
MEG, however, is less of a burden for patient and hospital and has no association 
with risk of increase in seizure frequency.  
Discussion: Routine MEG with visual assessment only is a reliable diagnostic tool in 
the routine diagnosis of epilepsy and may replace or precede EEG after sleep 
deprivation in daily clinical practice. Furthermore, MEG together with MRI enables 
magnetic source imaging (MSI) and, thus may provide additional information on the 
cortical localization of the epilepsy of a patient.   
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Introduction 
 
The occurrence of epileptiform discharges in the electroencephalogram (EEG) is of 
great value for the clinician to confirm the clinical diagnosis of epilepsy and to classify 
the epilepsy syndrome (Commission on Classification and Terminology of the ILAE 
1989). 
Unfortunately, sensitivity of routine EEG is rather low, ranging from 40% (Walter, 
Hodge and Hutchinson 1951) to 49% (Binnie and Stefan 1999), increasing to 68% 
when recorded within 2 days after a seizure (Sundaram 1990). If routine EEG is not 
conclusive additional EEG examinations (e.g. EEG after sleep deprivation, 
ambulatory 24-hours EEG) should be performed. Subsequently, in 85 to 92% of all 
patients with epilepsy epileptiform or focal activity can be shown (Werkgroep 
richtlijnen epilepsie 2006, Leach 2006). 
Sleep deprivation in patients with epilepsy has considerable disadvantages. Sleep 
deprivation can elicit seizures (Rajne and Veres 1993, Scalise 2006), has been 
reported as precipitating seizures from the days of Hippocrates (Lloyd 1983) and still 
is one of the three most important seizure precipitating factors mentioned by patients 
in questionnaires (Frucht 2000, Malow 2004, Nakken 2005, Tan 2005). Furthermore, 
to perform an EEG after sleep deprivation adequately a night of sleep deprivation is 
required. Despite all good intentions in the normal setting at home most patients have 
problems complying to the instructions. Therefor, in most cases hospitalisation 
should be performed. Moreover, sleep deprivation is a rather patient unfriendly 
procedure; having to stay awake during a night is hard for most people and can 
deregulate the diurnal rhythm for several days. Some patients have complaints that 
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remind them of “jet lag”. Finally, in most centres once again electrodes have to be 
applied, including the irritating scratching of the skin of the head to reduce 
impedance and gluing.  
It is argued in this paper that magnetoencephalography (MEG) is an alternative and 
more patient friendly way to detect epileptiform discharges, potentially with great 
diagnostic value in this early stage of the diagnostic process. Currently, MEG is 
mainly used in pre-surgical workup, where it is very helpful in localizing epileptiform 
activity (e.g. Stefan 2003, Knowlton and Shih 2004, Pataraia 2004, Rampp and 
Stefan 2007). More recently automated procedures for classifying and localizing 
interictal epileptiform discharges (IED) were developed (Oishi 2006, Ossenblok 2007) 
that enable the use of MEG in the diagnostic process of epilepsy.  
In these and other studies (e.g. Park 2004, Iwasaki 2005) of patients with neocortical 
localization related epilepsy as well as in theoretical model studies of, among others, 
de Jongh et al (2005) and Ramantani et al 2006 MEG has been shown to be more 
sensitive to the presence of epileptiform activity as compared to simultaneously 
recorded scalp EEG, each entity being complementary to the other. Especially in 
lateral (Lin 2003) and frontal (Ossenblok 2007) foci, MEG has been shown to be 
more sensitive than EEG. Aforementioned authors mostly compared MEG and EEG 
based on the analysis of single or clustered spikes. Knake et al (2006) and Kirsch, 
Mantle and Nagarajan (2007) however used another concept. They compared MEG 
and simultaneously recorded EEG based on the overall conclusion taking the entire 
study (either MEG or EEG) into account. Using this approach they showed more or 
less equal sensitivity between simultaneously recorded EEG and MEG. We intend to 
use the same conclusion driven approach when analysing our data. Our main goal, 
however, is to investigate whether MEG can be used in the primary diagnostic 
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process of epilepsy in patients suspected of having neocortical epilepsy. As routine 
EEG is readily available in all centers and independent of patient’s cooperation, we 
place the comparison one step later in the diagnostic process. Based on the higher 
spike sensitivity of MEG as compared to EEG in neocortical epilepsy (de Jongh 
2003) we hypothesized that visually analysed routine MEG after an inconclusive 
routine EEG would be able to prevent more unpleasant additional EEG-examination 
after sleep deprivation in a considerable percentage of patients. We therefor 
analysed the diagnostic gain of a routine MEG after a routine EEG. To allow an 
estimate of the influence of vigilance on outcome we determined presence or 
absence of sleep in the MEG-files and compared these data to the vigilance data 
retrieved from the EEG-reports of the same patients. 
Furthermore, the procedures developed in this study will make it easier to apply MEG 
in every day clinical practice. 
 
Methods 
 
Patients 
We included 51 patients referred to the out-patient clinic of Kempenhaeghe, a tertiary 
referral centre for epilepsy. The reasons for referral varied from uncertainty of 
diagnosis to lack of response to medication. 
Inclusion criteria were age over 6 years, suspicion of neocortical localization related 
epilepsy and a non-conclusive routine EEG. As in our centre only patients with an 
inconclusive routine EEG undergo additional examinations directly after this EEG, the 
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presence of this combination was used as criterion to include the patients in the 
study. 
Exclusion criteria were (very) high suspicion of non-epileptic seizures on clinical 
grounds, prior EEG with epileptiform discharges and medication change before 
routine MEG could be performed, presence of intracranial metals, pacemakers or 
pumps and inability to cooperate.  
In 29 patients EEG examination was done in order to confirm the clinical diagnosis of 
epilepsy. Interestingly, in 8 of these patients anti-epileptic drugs had already been 
started. In the other 22 patients the main question concerned the localization of the 
irritative zone.  
Semiology suggested epilepsy but left room for the diagnosis of non-epileptic 
“seizures” (PNES) in 5 patients. As PNES was not the primary differential diagnosis, 
these 5 patients were still selected.  In 3 patients, history only mentioned nocturnal 
generalized tonic clonic seizures. In 8 patients, the referring clinicians did not 
describe a clear hypothesis on the origin of the complaints noted. In all other 35 
patients description of the seizures led to a strong clinical suspicion of localization 
related epilepsy of neocortical origin. In 29 of these patients semiology led to a 
clinically more robust localization hypothesis. 
Routine EEG performed in Kempenhaeghe before inclusion in the present study was 
strictly normal in only 15 patients. The abnormalities in the remaining 36 routine 
EEG’s were focal slow waves, sharp waves of low amplitude not fitting the ILAE-
criteria of epileptiform discharges but recurring in more or less the same region, 
diffuse slowing and/or beta-activity and asymmetry of occipital rhythm. 
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The local medical ethical committee approved the study protocol. All patients signed 
an informed consent. 
Gender Age Semiology 
suggested 
Already 
treated 
MRI 
Male 26 Mean 
43.4 
Temporal 
neocortical 9 
32 (59%) Not available 7 
Female 
28 
Range 
16-72 
Extratemporal 21  No abnormalities 31 
  Unclear 24  Cortical 
abnormalities 7 
    
Only white matter 
abnormalities 9 
 
Table 1. Patient characteristics. 
 
Recordings 
In the days after the EEG-recordings, patients meeting the criteria as stated above 
were asked to participate in this study. Those who signed the informed consent 
underwent a routine MEG within 2 to 5 weeks after the EEG. To prevent a change in 
frequency of interictal abnormalities due to the sleep deprivation MEG recordings 
were not to be made within the first 2 weeks after a sleep deprivation.  
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MEG was performed at the MEG-centre of the Free University (VU) medical centre in 
Amsterdam, The Netherlands. We did not co-register EEG nor did we synchronize 
video and MEG. The MEG recordings were carried out using a 151-channel whole 
head MEG system with a base length of 5 cm (VSM Inc., Vancouver, BC, Canada). 
Squid noise levels were below 10 fT/Hz. Recordings were made with third order 
gradiometer noise cancellation. The anti-aliasing filter of the CTF hardware system 
was set to 200 Hz and the data were sampled at 625 Hz. 
All MEGs were recorded with the patient in supine position with a total patient 
examination time amounting up to 45 minutes. The procedure included after a test file 
of 5 min, periods of opening and closing eyes (10 min), eyes closed (5 min), making 
a left or right fist (5 min), hyperventilation (5 min) and finally a period of relaxation (15 
min).  These procedures match the procedures used during routine EEG recordings, 
except for photo stimulation. Furthermore, before each recording of a file, a head 
localization was performed using head coils located at three anatomical landmarks, 
impressions before the left and right ear and the nasion. This was done in order to be 
able to correlate the estimated equivalent current dipoles to an MRI if required. 
 
Visual review and analysis 
MEG data were visually analyzed at Kempenhaeghe in accordance to current clinical 
practice. 
As this study aims at investigating clinical feasibility of MEG, for screening of the 
MEG we devised a basic derivation consisting of 31 sensors distributed all over the 
head plus ECG (our “Routine MEG”-derivation, fig 1). In this derivation all regions are 
visible without loosing details in the abundance of data. As all sensors are recorded 
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and stored, visual analysis was expanded with other sensors when needed. For 
example, if on clinical grounds a clear hypothesis on the location of the epileptogenic 
zone was present that region would be looked at in closer detail. We evaluated the 
robustness of this approach by complete visual review of at randomly chosen in total 
10 files of 10 minutes in 10 different patients with all 151 channels visible instead of 
“only” the routine derivation. The ‘complete visual review’ did not reveal new 
abnormalities that changed the conclusion in the report. We therefor accepted this 
protocol as being sufficient for our purpose. 
10 sec
2.
0 
pT
Fi
el
d 
(pT
)
Figure 1. Example of “Routine MEG” showing a left temporal spike-wave with a spike 
maximum indicated by a vertical line. Insert: of all the recorded 151 sensors, as 
shown, in routine MEG only the sensors in red are shown on screen. 
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The MEG files were anonymized and were rated without a prior knowledge of the 
outcome of previous EEGs. Epileptiform activity was defined as a sharp transient 
different from background activity with an “epileptiform” morphology and a plausible 
spatial distribution, as is recommended for EEG by the International Federation of 
Clinical Neurophysiology (Cobb 1983). As MEG files were only available on a 10 
seconds base we evaluated the presence of sleep on a 10 second epoch base. 
Vigilance was divided into wake, drowsy and sleep. If there was only one epoch in a 
row with sleep stage 1 or 2 this was scored as drowsy. Rating was performed visually 
both by a skilled technician (W.D. or E.J. for epileptiform transients, LH. for vigilance) 
and by a skilled certified clinical neurophysiologist (A.C. or L.N.) independently and 
thereafter discussed to reach consensus, as is our current clinical standard 
procedure in evaluation of EEG-recordings.  
Results of the EEG after sleep deprivation of the same patients were obtained 
retrospectively from the patients charts, as were data on vigilance in routine EEG’s. 
At last, for patients for whom the main question concerned the localization of the 
irritative zone magnetic source imaging (MSI) was performed, according to the 
protocol previously described for automated classification and localization of IEDs 
(Ossenblok 2007).  
 
Study design 
In order to formulate a hypothesis on the probable diagnosis semiology as described 
by the treating physician was studied, including localization and if possible 
lateralisation. 
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MEG findings were categorized as “epileptiform” (multiple spikes < 70 ms, clearly 
distinguishable from the background), “suggestive for epilepsy” (recurrent but less 
pronounced sharp activity, sharp-slow wave complexes), “other abnormalities” and 
“no abnormalities”. This is the same categorization that is used in Kempenhaeghe for 
visual EEG-coding. As in most cases the combination of history, including ictal data, 
and clinical neurophysiological findings being categorized either as “epileptiform” or 
“suggestive for epilepsy” is sufficient for the clinician to diagnose epilepsy, these two 
were grouped in the analysis. 
MEG reports were sent to the referring physician, in concordance with every day 
clinical practice for EEG reports. The final diagnosis from the clinician based on all 
available information (that is, including the results from EEG and MEG) was taken 
from the patient chart and considered as the gold standard of diagnosis. The 
clinician’s assessments were categorized as “epilepsy” (including probable epilepsy, 
leading to the decision to start anti-epileptic drug treatment), “no epilepsy” and 
“uncertain”.  
 
Results 
Visual analysis of the MEG recordings of the 51 patients studied showed epileptiform 
discharges in 16 of the 51 patients. Another 16 MEG recordings showed sharp 
abnormalities suggestive for epilepsy, however, these were less pronounced. In 14 
patients there were other non-specific abnormalities, while in 5 patients MEG did not 
reveal any abnormalities.  
The results of the comparison of, respectively, MEG and EEG after sleep deprivation 
to clinical diagnosis are listed in table 2. The clinical diagnosis in the 16 patients with 
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epileptiform discharges was “epilepsy” in 15, “uncertain” in 1. In the group of 16 
patients with MEG findings suggestive for epilepsy, the final conclusion was 
“epilepsy” in 12, “uncertain” in 4.  
 
   Clinical diagnosis   
  No epilepsy Diagnosis uncertain Epilepsy Total 
 No abnormalities 1 1 3 5 
MEG Other abnormalities 2 5 7 14 
 Supportive of epilepsy 0 4 12 16 
 Epileptiform 0 1 15 16 
 Total 3 11 37 51 
 
   Clinical diagnosis   
  No epilepsy Diagnosis uncertain Epilepsy Total 
 No abnormalities 2 2 1 5 
EEG Other abnormalities 1 3 13 17 
 Supportive of epilepsy 0 6 12 18 
 Epileptiform 0 0 11 11 
 Total 3 11 37 51 
Table 2. Results of routine MEG and EEG after sleep deprivation vs clinical diagnosis 
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When pooling the groups with epileptiform discharges and with sharp abnormalities 
supportive of epilepsy, MEG was suggestive for the diagnosis of epilepsy in 32 of 51 
patients (63%). In 7 of the 37 patients with the clinical conclusion of “epilepsy”, MEG 
did not support the diagnosis of epilepsy. In 2 patients, despite support from MEG 
findings, the clinician did not (yet) decide on the diagnosis of epilepsy. In the 51 
EEG’s after sleep deprivation (that were made in all of these patients as it was one of 
the inclusion criteria) the conclusion of the clinical neurophysiologist stated 
“epileptiform” in 11 patients and “suggestive of the diagnosis of epilepsy” in 18 
patients. If we compare these results to the MEG spike yield it appears that none of 
these patients had a normal MEG (table 3). In total 5 EEG’s after sleep deprivation 
showed “no abnormalities”. In the remaining 17 the conclusion was “other 
abnormalities”. These EEG’s were therefor supportive of the diagnosis of epilepsy in 
29 of 51 patients (57%). In 11 of the 37 patients with the clinical conclusion of 
epilepsy EEG after sleep deprivation did not support the diagnosis of epilepsy.  
The comparison between MEG category and clinical conclusion and the results of the 
EEG’s after sleep deprivation compared to those of the MEG and to the clinical 
conclusion are summarized in tables 2 and 3. Table 4 shows the vigilance state of 
the patients during the different recording modalities. In both routine EEG and routine 
MEG, about the same number of patients did not have an altered vigilance 
whatsoever, whereas almost all patients reached sleep during EEG after sleep 
deprivation. 
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   EEG    
  No 
abnormalities 
Other 
abnormalities 
Supportive of 
epilepsy 
Epileptiform total 
 No abnormalities 4 1 0 0 5 
MEG Other 
abnormalities 
1 13 1 0 14 
 Supportive of 
epilepsy 
0 3 12 1 16 
 Epileptiform 
 
0 1 5 10 16 
 Total 5 17 18 11 51 
Table 3. Results of routine MEG vs results of EEG after sleep deprivation 
 wake drowsy Sleep 
RT EEG 13 19 19 
SD EEG 0 1 50 
RT MEG 13 17 21 
Table 4. Lowest vigilance during the recording. Noted the number of patients 
reaching a specific vigilance state. Wake: not even drowsy. Drowsy: no actual sleep. 
Sleep: actual sleep recorded. RT EEG: routine EEG. SD EEG: EEG after sleep 
deprivation. RT MEG: routine MEG 
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In the original subgroup of 29 patients primarily recorded to support the diagnostic 
process MEG findings supported the diagnosis in 15 (52%) of these patients.  
Interestingly, in the subgroup of 22 patients primarily recorded to localize the epileptic 
(or irritative) zone, in 2 patients the clinicians diagnosis changed from “very probable 
epilepsy” to “localization related epilepsy” based on the MEG results. This reflects the 
fact that the diagnosis of epilepsy does not mandatory requires the presence of EEG-
abnormalities, but that a clinician does feel reassured in diagnosing epilepsy when 
neurophysiological data support this diagnosis. In the remaining 20 of these 22 
patients the diagnosis remained unchanged, i.e. localization related epilepsy. In 15 of 
these  22 patients a sufficient number of spikes (10 or more) was obtained to enable 
the automated procedures for grouping and localizing of the spikes, as developed by 
Van ‘t Ent et al. (2003). These procedures yielded for 8 of these 15 patients a 
localized irritative zone, in the temporal regions for 3 patients and in the 
extratemporal regions for the other 5 patients. For example, for one of the patients 
with temporal lobe localization previous routine EEG as well as EEG after sleep 
deprivation in our centre did not show any specific epileptiform discharges either. 
Semiology of the seizures pointed to a probably left-sided, neocortical epileptogenic 
zone, possibly in the posterior temporal region or the temporo-parieto-occipital 
junction. MRI showed right (!) frontal gliotic tissue. For this patient, MEG played a 
pivotal role in fine tuning the diagnosis of this patient’s epilepsy. The interictal MEG 
shown in figure 1 and representation of the equivalent dipole analysis in fig 2 indicate 
that the epilepsy of this patient originates in the left temporal lobe, at a location 
bordering the transverse temporal gyrus. 
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Figure 2. The density of the equivalent dipoles, fitted at an epoch across the 
maximum of the averaged spikes with similar field distribution (left), is plotted at the 
sagittal, coronal and axial MR-scans of the patient (bottom right). The vector 
representation ( e.g. location and direction) of the equivalent dipoles (%err < 5) 
plotted at the coronal MR-scan of the patient (upper right) 
 
Discussion 
For a specified group of patients from the out-patient clinic of Kempenhaeghe, a 
tertiary referral center for epilepsy, with probable localization related neocortical 
epilepsy and with inconclusive standard EEG we found that MEG provided additional 
information leading to the diagnosis of epilepsy in 63% of the patients. Taking the 
clinical diagnosis as gold standard and excluding the 11 patients in whom the “final” 
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diagnosis was uncertain there were 27% false negatives and no false positives. This 
performance is in the range of EEG after sleep deprivation in the same patients, in 
whom we found a gain of 57% and with the same restriction 38% false negatives and 
no false positives. The absence of false positives probably partly is due to the trust 
clinicians have in clinical neurophysiologists. Therefor, it is of utmost importance that 
clinical neurophysiologists do not conclude too easily that a recording is epileptiform 
and in their conclusion correlate findings in the recordings with clinical data provided 
by the attending neurologist. We are very aware of this fact. 
We consider routine MEG to be more patient friendly than EEG after sleep 
deprivation the way it is done in our center. Our procedure includes a night of 
hospitalization with a dedicated watch to ensure complete sleep deprivation followed 
by a recording of 4 hours. In most hospitals partial sleep deprivation is considered 
sufficient, whether or not during hospitalization with shorter recording. The underlying 
thought is that the most important goal of this procedure is to record EEG during 
sleep. There is, however, “a long-standing discussion on the usefulness of sleep and 
sleep deprivation as activating methods in electroencephalographic recordings” 
(Roupakiotis 2000) with a tendency to favor the specific activating role of sleep 
deprivation per se (Fountain, Kim and Lee 1998). e.g. Degen, Degen and Reker 
(1987) did not find a clinically useful difference between sleep EEG with or without 24 
hour sleep deprivation. The first was achieved by administering promazine 
hydrochloride. They did, however, find significantly more epileptic discharges in the 
sleep EEGs after sleep deprivation. 
Even accepting the fact that sleep deprivation in itself causes a rise of epileptiform 
discharges one can dispute the necessity of 24 hours of sleep deprivation. 
Unfortunately, even 24 hours of sleep deprivation does not ensure sleep during the 
44 
 
EEG the next day. After only partial sleep deprivation percentages of patients above 
8 years reaching sleep during the subsequent EEG already range from 64% 
(Liamsuan 2000) to 91% (Peraita-Adrados 2001). In a review by Ellingson, Wilken 
and Bennett (1984) it is stated that “there is no good reason for not using it (partial 
sleep deprivation) routinely”.  This, however, is not supported by any direct 
comparison between results after complete and partial sleep deprivation. Our 
percentage of patients reaching sleep after a night of sleep deprivation is 
considerably higher than the figures mentioned in the above mentioned literature. 
Partly this might be due to our policy of complete sleep deprivation during the night. 
Another factor could be the location of our EEG laboratory in the middle of the woods 
without major sources of noise in the vicinity. The most important factor, however, 
probably is the length of our recordings. Time to sleep onset varied between 0.5 and 
49 minutes, indicating that a longer recording time will give a higher chance of 
reaching sleep. Accepting the evidence that sleep deprivation per se is an activating 
factor for epileptiform activity in the EEG we prefer a period of 24 hours of sleep 
deprivation above a partial sleep deprivation. 
As the procedure in routine MEG mimics that in routine EEG we did not expect much 
difference on the level of vigilance. Indeed in this respect there was no difference 
between these two recordings. As the presence of sleep greatly enhances the 
chance of finding epileptiform phenomena in the EEG of patients with epilepsy (e.g. 
Gibbs and Gibbs 1947, Viteri 2007) this might also be true for MEG-recordings. 
Based solely on the covariant sleep the gain of routine MEG would be expected to be 
the same as of routine EEG. Also, in our EEG’s after sleep deprivation the 
percentage of patients achieving a considerable amount of sleep is quite higher than 
in MEG whilst the gain is comparable. Therefor, the gain of MEG cannot be due to 
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sleep alone. Therefor, if routine MEG does not support the diagnosis of epilepsy in a 
patient with high suspicion of epilepsy performing an MEG after sleep deprivation 
might even be more sensitive than an EEG after sleep deprivation. This, however, 
falls outside the scope of the present study. 
Furthermore, routine MEG even is more patient friendly and less time consuming 
than any EEG recording, because application of electrodes might be unpleasant and 
preparation and cleaning time is much less for MEG than for EEG. In comparison, a 
routine EEG recording of one hour takes about two hours from starting the 
preparation to departure of the patient and EEG recording after sleep deprivation 
takes up to five hours in our center, whereas a complete routine MEG recording can 
be done within about 1 hour of patient time. Furthermore, using our protocol for 
analysis, MEG takes about as much time as thorough analysis of routine EEG and 
about half the time of analyzing an EEG after sleep deprivation. Apart from the 
benefits of patient friendliness, less time-consuming for technicians and patients 
there is the “free” extra of being able to perform localization if localization is of utmost 
importance, e.g. if the possibility of epilepsy surgery evaluation is considered. The 
automated procedures for classifying and localizing the interictal discharges (De 
Munck 2001; Van ‘t Ent 2003; Ossenblok 2007) immediately provides the clinician 
with an overview of the nature and if feasible the location of the sources underlying 
the interictal epileptiform discharges, as shown in figure 2. Especially, if the 
epileptiform discharges originate in an area bordering the sulcus in between temporal 
and frontal lobe (see figure 2) these are more easily demonstrated by MEG than by 
EEG (Ossenblok 2007). Thus, for this group of patients MEG can be of importance in 
case of presurgical evaluation. Manual detection of interictal epileptiform discharges 
in MEG is, however, time consuming, because the rater will need extra time to put 
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markers in the files, a 3D-MRI will have to be performed including extra time for 
classifying and localizing the interictal events. At the moment this might be somewhat 
overdone for every day clinical practice and should only be performed when the 
question of the clinician regards the location of the cortical origin of the epilepsy of 
the patient. Further development and implementation of automated detection of 
interictal events will probably allow localization on a more routine base in the future.  
At the moment, however, MEG systems are still rather expensive and require a 
magnetic shielded room (comparable to the first MRI-systems) whereas a 
sophisticated EEG system is already present in most clinical settings (comparable to 
the presence of CT-systems in former days), at present using routine-MEG as 
primary diagnostic tool for epilepsy will be the privilege of epilepsy centers or centers 
who already posses or consider acquiring an MEG system for other purposes as well.  
On the other hand, depending on the local costs of factors like a night of 
hospitalization, a dedicated nurse or host to keep the patient awake during the night 
and some extra time for the technician and the frequency at which at present an EEG 
after sleep deprivation is recorded in a specific institute, acquiring MEG equipment 
might even be of financial benefit.  
 
As Kempenhaeghe is a tertiary epilepsy centre, our patient group will not necessarily 
reflect the patient group as seen in other hospitals, since in a tertiary epilepsy centre 
the chances of diagnosing epilepsy are much higher than in other hospitals. Therefor, 
we expect that the gain of diagnostic tools in our centre might be higher than in 
normal hospitals. Combined with the exclusion criterion of high suspicion of non-
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epileptic seizures, this also explains why the percentage of patients with epilepsy 
according to the final clinical assessment is so high. 
There is no definite proof that the patients in our study with abnormalities in EEG or 
MEG supportive of the diagnosis actually have epilepsy. EEG and MEG can only 
increase the probability of this diagnosis. The diagnosis of epilepsy is a clinical one. 
Even in patients with definite epilepsy combined routine EEG and EEG after sleep 
deprivation show epileptiform discharges in only 85% of the patients (richtlijnen 
NVvN, guidelines national neurological society). Also, in perfectly healthy candidates 
for aircrew training unequivocal epileptiform discharges can be found in up to 0.5 %, 
almost half of them without photic stimulation (Gregory, Oates and Merry 1993).  
Therefor, clinical neurophysiologic data are supportive of the diagnosis at best. In our 
centre, the EEG is considered supportive if there is a clear epileptiform focus or 
pattern or if clinical features are concurrent with focal, preferably sharp abnormalities 
resembling epileptiform patterns. Therefor we pooled the groups with epileptiform 
discharges and with sharp abnormalities suggestive for epilepsy. 
MEG as a routine tool in clinical neurophysiology is still under development. Brain 
activity appears to be sharper when measured with MEG (Fernandes 2005, 
Ossenblok 2007) and there still is debate on what the criteria should be for naming a 
grapho-element in MEG epileptiform (Zijlmans 2002). Therefor, we took a 
conservative approach to determining MEG grapho-elements “epileptiform”. Once 
criteria for naming a grapho-element epileptiform become clearer, the group in which 
epilepsy is thought to be proven might grow at the expense of the group with less 
specific features, e.g. “sharp abnormalities suggestive for epilepsy”. However, looking 
back at our data at the end of the data collection period we still discarded for several 
patients several visually detected phenomena as probably not being epileptiform but 
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more likely sharp mu rhythm, POSTs or benign epileptiform transients of sleep 
(BETS). These phenomena, identified initially as (suspicious of) interictal epileptiform 
events, appeared to be i.e. discordant with clinical suspicion, while in some of these 
patients the same phenomena were described in the routine EEG or EEG after sleep 
deprivation as being probably non-epileptic. Also, we encountered above mentioned 
phenomena in several patients in whom the localization of these phenomena were 
discordant with clinical suspicion while in the same patient there were also spikes 
that were concordant with clinical suspicion. Furthermore, in several patients MEG 
turned out to show a lot of activity that did not resemble EEG in the basal temporal 
regions. For example, in figure 1 apart from the spike and waves maximal at the left 
temporal lobe sensors sharp paroxysmal activity occurs, more or less symmetrically 
at the temporal and occipital lobe sensors of this patient. We learned from this study 
that whenever the sharp transients in the temporal regions either may indicate a left, 
right or symmetric temporal distribution for a small number of detected events one 
should be aware that these are false detections due to sharp MEG components, 
which may become apparent, especially, in the temporal regions.  Acquiring a vast 
experience with “normal” MEG in the coming years will prove of utmost importance to 
better distinguish the physiological variants. As this is not the case yet, the authors 
cannot emphasize enough the caution a clinical neurophysiologist should apply 
before stating the MEG is epileptiform. Furthermore, in order to validate the outcome 
and give a more reliable estimation on sensitivity and specificity of the tests used, 
patients will be re-evaluated 8 years after enrollment in this study. They will be asked 
again to supply their medical history with special regard to the occurrence of seizures 
and the clinical diagnosis of epilepsy. This data will be correlated with the present 
results of the routine MEG-recordings. 
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Conclusion: 
We have shown that routine MEG is a reliable diagnostic tool in the routine diagnosis 
of epilepsy when the first EEG is negative or inconclusive. None of the patients with 
findings on EEG after sleep deprivation supporting the diagnosis of epilepsy had a 
negative MEG. For the patients studied the diagnostic gain of MEG recorded 
routinely did not differ significantly from the diagnostic gain of EEG after sleep 
deprivation performed after a non-conclusive routine EEG examination. When taking 
other factors into account, like patient friendliness and duration of the examination 
MEG, when already available, and not EEG after sleep deprivation could be the 
investigation of first choice. Financial issues are still the major obstacles. However, 
one should keep in mind that a high degree of cooperation is required to perform a 
MEG as the patient is required not to move his or her head, making it inapt for long 
term monitoring and registration of restless or uncooperative patients. 
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3.2 Long-term reliability of MEG outcome 
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Abstract  
Objective: MEG and EEG after sleep deprivation (EEG-SD) are applied as diagnostic 
tools in the evaluation of patients with possible epilepsy. There is no gold standard to 
check whether the diagnosis based on these two modalities is correct. The best 
standard available is the long-term follow-up of patients. As follow-up of an earlier 
study in which the additional value of MEG vs EEG-SD diagnosis was evaluated, we 
investigated the long-term validity of MEG-based and EEG-SD-based diagnosis. 
Materials and methods: Data collected from 46 patients were used in a comparative 
study of the last known diagnosis against the original one of 8 years ago. 
Results: Long-term (3–8 years) sensitivity of sharp phenomena (combining spikes 
and sharp waves) in routine MEG and in EEG-SD for the diagnosis epilepsy is 71% 
and 62%, respectively. When compared to the original study, this hardly changed. 
Over time, uncertainty on diagnosis diminishes. 
Conclusion: MEG as well as EEG-SD are robust long-term predictors for epilepsy. 
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Introduction 
Epilepsy has a profound and long-term impact on life. It can have a major impact on 
socio-economic factors (i.e. restrictions in work, restrictions in driving, social stigma 
(e.g. [Van Mil 2009, Taylor 2011, Jacoby 2014]) and can lead to lifelong use of 
medication. Therefor, it is of utmost importance to avoid an erroneous diagnosis. On 
the other hand, it is also important to correctly diagnose epilepsy in order to start the 
optimal treatment. To determine whether or not a particular patient has epilepsy, 
several tools are available. The most important of these is the medical history, 
including description of the alleged seizures and the changes in clinical symptoms 
over time. Further support for diagnosis can be found in video recordings, structural 
imaging (CT or MRI), and above all electrophysiological investigations. Routine 
electroencephalogram (EEG) and EEG after sleep deprivation (EEG-SD) are mostly 
used. Long-term video-EEG (LTM) capturing events are considered to provide the 
highest level of security on the diagnosis. It changes diagnosis in up to 58% of 
patients [Ghougassian 2004]. However, even in the highly selected population 
undergoing this time-consuming and expensive investigation in up to 5.2%, it neither 
helps to improve the diagnosis nor the management [Baheti 2011]. And LTM certainly 
is not a standard procedure applied in all diagnostic processes. Therefor, while in a 
limited number of cases an unequivocal diagnosis can be made, there is no gold 
standard proving that a person does not have epilepsy. Decades after the first 
description of the occipital alpha, rhythm producing a detectable magnetic field 
[Cohen 1968] magnetoencephalography (MEG) is also gaining ground, both in the 
primary diagnosis of epilepsy and in the presurgical evaluation of patients with drug-
resistant epilepsy [Ossenblok 2007, Colon 2009, Heers 2010, De Tiege 2012]. 
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Despite the prominent role of neurophysiologic investigations in diagnosing epilepsy, 
to our knowledge there are no studies addressing the long-term validation of EEG-
SD, let alone of MEG as diagnostic tools for epilepsy. In an earlier study, we showed 
that for patients who all had a negative routine EEG, routine MEG was as supportive 
for diagnosing epilepsy as EEG-SD [Colon 2009]. In the present study, we examined 
the changes in diagnosis 3–8 years after the actual MEG and EEG-SD examinations. 
  
Materials and methods 
Included were all patients that participated in our earlier study on the use of MEG for 
primary diagnosis [Colon 2009]. Inclusion criteria for this study included age over 6 
years, suspicion of neocortical extratemporal localization-related epilepsy, and an 
inconclusive routine EEG, including provocation trials of hyperventilation and 
photostimulation. Results of visually assessed MEG recordings were compared, 
retrospectively, with clinical data and with the results of EEG-SD. Encephalographies 
were considered supportive for the diagnosis of epilepsy if there was a clear 
epileptiform focus or pattern or clinical features were concordant with focal, 
preferably sharp abnormalities resembling epileptiform patterns. Therefor, groups 
with epileptiform discharges and with sharp abnormalities suggestive for epilepsy 
were pooled in the final analysis. MEG and EEG-SD examinations were performed in 
2005 or 2006. In routine EEG as well as in EEG-SD, recording time was 1 h. In MEG, 
in total 45 min were recorded. Sleep deprivation was carried out clinically and lasted 
until 7 a.m. Results were compared to our ‘gold’ standard: the final diagnosis made 
by the treating epileptologist. This diagnosis therefor was an expert opinion, based 
on all the data deemed necessary or sufficient by this epileptologist to make a 
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diagnosis. For this study, the same patients were sent a questionnaire asking about 
their medical history in the past years, their present diagnosis, and present use of 
anti-epileptic drugs. They were asked, furthermore, permission to collect further 
information from the family physician or to use information available from our 
institute. Information of last follow-up, either via the returned questionnaire, by 
information from the family physician or available in our charts was added to the 
original database. Diagnosis at last follow-up by a neurologist was noted, plus 
reasons for chance of diagnosis (Table 1) if applicable.  
 
Table 1. Reason of changed diagnoses in the eight patients in whom original diagnosis is thought to be false 
Patient 
Initial 
diagnosis 
Diagnosis at last 
FU 
Reason of change 
1 Uncertain Epilepsy Tonic-clonic seizure 
2 Uncertain Epilepsy 
Finding of MRI abnormality on plausible location by applying voxel-based 
morphology analysis 
3 Uncertain Epilepsy Partial seizure during routine EEG 
4 Uncertain Epilepsy Cell phone video of seizure 
5 Uncertain Not epilepsy Without treatment abrupt cessation of seizures after explanatory talk 
6 Uncertain Not epilepsy Proven Syncope (tilt-table test) 
7 Epilepsy Uncertain Unclear from files. Probably the emerging psychiatric abnormalities 
8 Epilepsy Not epilepsy Change of symptoms to bizarre semiology 
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Classification of the encephalographies was taken from the former study, and thus 
categorized as epileptiform (multiple spikes <70 ms, clearly distinguishable from the 
background [Cobb 1983, Pedley 1980]), ‘suggestive for epilepsy’ (recurrent but less-
pronounced sharp activity of 70–200 ms, sharp–slow wave complexes), ‘other 
abnormalities’, or ‘no abnormalities’. In Table 2, the original diagnosis after review of 
the routine EEG, EEG-SD, and MEG is listed vs the results of the review. In 
comparison, Table 3 contains the same results of review of EEG-SD and MEG, but 
now listed vs the diagnosis at last follow-up.  
In line with the original study, to obtain a sensitivity and specificity percentage, the 
encephalography results were pooled in two categories: epilepsy (Spikes plus sharp 
waves) and no epilepsy (other and no abnormalities). For specificity calculation, the 
diagnostic groups of epilepsy and uncertain were pooled as ‘other’, whereas for 
sensitivity calculation the diagnostic groups of uncertain diagnosis and no epilepsy 
were pooled as ‘other’ (Tables 4 and 5), thus eliminating the uncertain diagnoses 
from the equations.
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 Table 2. Results of routine MEG and EEG after sleep deprivation vs original clinical diagnosis 
  
Clinical diagnosis 
No epilepsy Diagnosis uncertain Epilepsy Total 
MEG 
No abnormalities 1 1 3 5 
Other abnormalities 2 5 7 14 
Supportive of epilepsy 0 4 12 16 
Epileptiform 0 1 15 16 
Total 3 11 37 51 
EEG 
No abnormalities 2 2 1 5 
Other abnormalities 1 3 13 17 
Supportive of epilepsy 0 6 12 18 
Epileptiform 0 0 11 11 
Total 3 11 37 51 
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Table 3. Results of routine MEG and EEG after sleep deprivation vs clinical diagnosis at last follow-up 
  
Last follow-up 
No epilepsy Diagnosis uncertain Epilepsy Total 
MEG 
No abnormalities 1 0 3 4 
Other abnormalities 3 2 7 12 
Supportive of epilepsy 2 2 10 14 
Epileptiform 0 2 14 16 
Total 6 6 34 46 
EEG 
No abnormalities 1 0 3 4 
Other abnormalities 1 4 10 15 
Supportive of epilepsy 4 1 11 16 
Epileptiform 0 1 10 11 
Total 6 6 34 46 
 
59 
 
 
Table 4. Specificity calculation at last follow-up. To be as pure as possible, ‘other’ includes patients in whom the 
diagnosis was ‘epilepsy’ plus those in whom the diagnosis was still uncertain 
  Diagnosis ‘other’ Diagnosis no epilepsy Total 
MEG 
Epilepsy 28 2 30 
No epilepsy 12 4 16 
Specificity   4/6*100 = 67%   
EEG-SD 
Epilepsy 23 4 27 
No epilepsy 17 2 19 
Specificity   2/6*100 = 33%   
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Table 5. Sensitivity calculation at last follow-up. To be as pure as possible, ‘other’ includes patients in whom the 
diagnosis was ‘no epilepsy’ plus those in whom the diagnosis was still uncertain 
  Diagnosis epilepsy Diagnosis ‘other’ Total 
1. EEG-SD, EEG after sleep deprivation. 
MEG 
Epilepsy 24 6 30 
No epilepsy 10 6 16 
Sensitivity 24/34*100 = 71%     
EEG-SD 
Epilepsy 21 6 27 
No epilepsy 13 6 19 
Sensitivity 21/34*100 = 62%     
 
The local medical ethical committee approved this study. Consent was assumed if 
the patient returned the questionnaire. 
 
Results 
A total of 46 of the 51 questionnaires were returned. One patient died, but the 
relatives allowed use of the data. Follow-up in this patient was 3 years. Three 
patients returned the questionnaire supplying data but not allowing to contact the 
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family physician. Follow-up of these patients in our own institute was 5, 6, and 8 
years, respectively. Follow-up in the remaining group was 8 years, in 29 patients 
based on information available in our institution and in an additional 13 patients also 
based on the information provided by the family physician. Follow-up of this last 
group in our own institute was 5–7 years. 
In only one of the included patients, Long Term Monitoring (LTM) was performed. 
This patient underwent extensive presurgical analysis, resulting in a successful right 
frontal resection. Both in the original study as in this review, this patient was 
considered to have a definite diagnosis of epilepsy. In eight of the patients, diagnosis 
changed over the years: in four from ‘diagnosis uncertain’ to ‘epilepsy’, in two from 
‘diagnosis uncertain’ to ‘not epilepsy’, in one from ‘epilepsy’ to ‘diagnosis uncertain’, 
and in one from ‘ epilepsy’ to ‘not epilepsy’. Reasons for change in diagnosis varied, 
as indicated in Table 1. In addition, four patients who now are diagnosed as having 
epilepsy developed a different event type next to the original, resulting in combined 
diagnoses of epileptic and non-epileptic seizures. In one of these four patients, this 
occurred after a cerebrovascular infarction. 
When pooling the groups with epileptiform discharges (spikes) and with sharp 
abnormalities supportive of epilepsy, the original MEG conclusion corresponded with 
the latest diagnosis of epilepsy in 24 (52%) patients, as compared to 53% at initial 
diagnosis. For EEG-SD that was true in 21 (46%) patients as compared to 45%. 
Including the patients with an (as yet) uncertain diagnosis but excluding those in 
whom epilepsy was ruled out, the gain of MEG was 61%, as compared to 63% of 
positive MEG diagnoses in the original group. For EEG-SD, these numbers were 
50%, coming from 57% initially. The percentage of uncertain diagnoses dropped over 
the 8-year follow-up from 22% to 13%. The percentage of patients with abnormalities 
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supportive of epilepsy but a diagnosis of no epilepsy, however, augmented during 
this follow-up from 0% to 4% for MEG and 9% for EEG-SD. There were no patients in 
our group with MEG or EEG-SD with spikes without a diagnosis of epilepsy. 
In the group of eight patients in whom diagnosis changed, six changed from 
uncertain to a definite diagnosis. Four had no sharp or epileptiform activity in their 
MEG nor in their EEG-SD. Two of these had MEG and EEG-SD abnormalities 
supportive of epilepsy, one of them changing to a diagnosis of epilepsy, one to a 
diagnosis of not epilepsy. In the patient in who the diagnosis changed from ‘epilepsy’ 
to ‘not epilepsy’ MEG and EEG-SD were supportive of epilepsy, whereas in the 
patient whose diagnosis changed from ‘epilepsy’ to ‘uncertain’ both MEG and EEG-
SD showed sharp waves but no spikes, thus supportive of epilepsy. 
Sensitivity and specificity of EEG-SD and MEG for epilepsy are, respectively, 62% 
and 33% (EEG-SD) vs 71% and 67% (MEG) (Tables 4 and 5).  
 
Discussion 
Over a time period of 3–8 years, there was no significant change in the positive 
predictive value of routine MEG or EEG-SD in our group of patients. However, there 
seems to be a trend for spikes and sharp waves to be rather more robust long-term 
predictors for definite epilepsy in MEG than in EEG-SD. Unfortunately, the size of this 
study is insufficient to make solid conclusions on this observation. Looking at 
epileptiform discharges in the strictest sense (spikes), there were no definite false 
positives. However, looking at patients with only sharp waves in MEG or EEG-SD, 
over time a larger portion of them was diagnosed as not having epilepsy. For EEG, in 
the past there has been some debate whether or not there is a difference between 
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spikes and sharp waves in predicting or confirming epilepsy [Pedley 1980, Walczak 
1997] This discussion seems to have ended by favoring the conclusion that both are 
equally supportive for diagnosing epilepsy (e.g. [Niedermeyer 1999]. Our present 
study including patients without epilepsy, albeit small, tends to favor the view that in 
the long-run spikes are more suggestive of epilepsy than sharp waves. Former 
studies were based on the first diagnosis or included only patients with an 
established diagnosis of epilepsy [Celesia 1976], whereas our study looks at the 
long-term consistency. In healthy adults, EEG can show sharp waves and spikes in 0 
up to 6.6% of the subjects [Gibbs 1943, Kooi 1964, Jabbari 2000]. We are not aware 
of similar studies on MEG; however, it is very likely that a small portion of normal 
controls will present the same phenomena in MEG as well. In our study, we initially 
did not find patients with epileptiform abnormalities in their encephalography in whom 
a clear diagnosis of no epilepsy was reached. However, in the present long-term 
analysis, this was 4% (2/46) and 7% (4/26) for MEG and EEG-SD, respectively, in all 
cases presence of sharp waves. All in all, we therefor advocate re-evaluation of the 
predictive value of spikes vs sharp waves and at present differentiating between 
them in describing EEG and MEG abnormalities in the context of epilepsy diagnosis. 
And to do so even more vigorously for EEG-SD than for MEG. The adagio ‘it is no 
epilepsy if the EEG/MEG is normal’ is false as well as the adagio ‘it is epilepsy if 
EEG/MEG contains sharp transients’. 
Diagnosis changed in 17% of the patients. In three quarters of them, over time the 
diagnosis changed from uncertain to certain. As there is no gold standard for 
diagnosing epilepsy, in some cases only time can tell. A change of diagnosis from 
epilepsy to no epilepsy has been described, mainly for PNES (psychogenic non-
epileptic seizures) with a mean latency between onset of PNES and final diagnosis 
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as being non-epileptic and psychogenic of approximately 7 years [Bodde 2009] but 
also for other entities like syncope. 
There is one study on long-term changes in EEG in epilepsy patients [Hughes 1985]. 
This study included only patients with ongoing seizures, thus excluding most of the 
group of patients of our study. However, changes in EEG pattern in this study 
occurred almost exclusively within 8 years. It is likely that possible changes in 
semiology would parallel a change in EEG pattern. We therefor believe that a period 
of 8 years is adequate to re-evaluate the patients included. 
There is no gold standard for diagnosing epilepsy, LTM is the best option available. 
Unfortunately, even apart from the tremendous costs of this procedure making it 
impossible to apply it in every patient, it is only suitable for patients with a higher 
frequency of seizures or events. Therefor, as ‘best available standard’, we used the 
clinical diagnosis at last follow-up. This might overestimate, especially, the number of 
patients in whom the diagnosis of epilepsy did not change as challenging a once-
made diagnosis of epilepsy is counterintuitive. In our center, it is standard procedure 
to re-evaluate a diagnosis every several years, even if clinical signs did not change. 
A follow-up of 8 years is long enough for all of our patients to have been re-analyzed. 
In the group of 13 patients, however, not still under our care we cannot guarantee the 
validity of the last diagnosis. As in this group there are six patients with the diagnosis 
of epilepsy and one with a still uncertain diagnosis this could influence our results. All 
changes in diagnosis took place while patients were under our care, including four 
patients that are part of this last group (three with a final diagnosis of ‘not epilepsy’, 
one with the diagnosis ‘epilepsy’). However, of the four patients in whom at present a 
mixed diagnosis of ‘epilepsy and non-epileptic seizures’ is noted, two have been 
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diagnosed outside of our center. This supports the notion that clinical changes 
influence diagnosis both in tertiary and secondary centers in the same way. 
The population analyzed in this study is biased by the fact that we recruited from a 
tertiary epilepsy center. The a priori chance of having epilepsy is much higher in our 
patient group than in a standard neurology practice. The underrepresentation of 
patients without epilepsy might have influenced the results to overestimate the gain 
of our encephalographys. This, however, should hardly be true for the consistency of 
gain over time. Both EEG-SD and MEG show a remarkable consistency in gain in the 
patient group with diagnosed epilepsy, even though there is some decline in gain in 
the patient group with no epilepsy or a still uncertain diagnosis, a bit more 
pronounced in the EEG-SD's than in the MEGs. As the response rate of our study 
was 90%, we obtained a good representation of our original group. The calculated 
specificity cannot be interpreted as correct, seen the low number of patients in whom 
the diagnosis is NOT definite epilepsy.  All in all we showed that the sensitivity of 
routine MEG in long term was 71%. The sensitivity of EEG-SD was 62%. For EEG-
SD, the sensitivity is in line with the reported activation after sleep deprivation, 
ranging from 34% to 84% in the literature [Mattson 1965, Spadette 1971, Giorgi 
2013]. However, these reports mainly are based on the appearance of spikes and 
sharp waves rather than diagnosis-specific sensitivity. In a recent comparison 
between primary generalized epilepsies and focal epilepsies [Renzel 2016], the 
sensitivity of EEG-SD for focal epilepsies was no higher than 17%. Inclusion criteria 
as well as recording time were almost equal to ours, so no good explanation for the 
difference can be found. 
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Conclusion 
Epileptiform abnormalities in MEG are even more robust long-term predictors for 
epilepsy than these abnormalities in EEG-SD. 
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CHAPTER 4 
MRI in Epilepsy 
4.1 MEG-guided MRS 
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and focal cortical dysplasia or a MEG-focus using 
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Abstract 
Purpose: To evaluate if single voxel proton magnetic resonance spectroscopy (SV-
MRS) can help in lateralising and sometimes in localizing an epileptogenic focus. The 
assumption is that in MRI negative patients the underlying pathology most often is 
focal cortical dysplasia (FCD). Several studies have shown that in the presence of 
FCD there are also 1H-MRS abnormalities on the contralateral side. However, in 
most cases the studied group was not homogeneous and included different forms of 
dysplasias, including band heterotopias and polymicrogyria, and the studies used 
different spectroscopy protocols. In the present study, using bilateral SV-MRS we 
investigated the presence of a lateralisation index in two groups of patients with 
localization related epilepsy: patients with focal cortical dysplasia on MRI and 
patients without MRI abnormalities with a focus identified by MEG. Aim of the study 
was to show that in both groups the expected epileptogenic side shows more 
pronounced metabolic alterations, making MRS a possible screening tool for 
clarifying lateralisation questions in patients with cryptogenic localization related 
epilepsy. Methods: In ten patients a single voxel was placed over the FCD and in 
nine patients over the region of interest (ROI) as indicated by MEG. In all patients a 
voxel was also placed in the contralateral homologous location. We used metabolite 
concentrations as peak ratios relative to the creatine (Cr) peak to calculate a 
lateralisation index. Results: In both groups NAA/Cr was significantly lower on the 
affected side whereas the results for Cho/Cr were more diverse. There were no 
significant differences between the two groups. The limitations of the used methods 
and the implications of the findings are discussed.  
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Introduction 
With the introduction of MRI in clinical practice the percentage of patients with 
cryptogenic localization related epilepsies diminished from 70% to 30%. However, 
despite the improvement of structural MRI techniques there are still a considerable 
number of patients with epilepsy left with a negative MRI study (von Oertzen 2002; 
Phal 2008). In case of intractable epilepsy of presumed extra-temporal origin this 
may prevent surgery or lower the chances of successful surgery in these patients. In 
most studies, the presence of a lesion on MRI and the possibility to resect the entire 
lesion are the major factors predicting successful outcome of surgery (e.g. Fauser 
2004; Krsek 2009). Therefor, a lot of effort is put into improving imaging techniques. 
With an a priory hypothesis on the probable location of a lesion more lesions can be 
detected by reviewing the MRI (Moore 2002). MEG is a very powerful tool to 
determine the epileptogenic focus or the irritative zone in patients with enough spikes 
in their traces (e.g. Ossenblok 1999; Shiraishi 2001; Van ‘t Ent 2003; Iida 2005; 
Papanicolaou 2005; Ossenblok 2007). There are several alternative MRI techniques 
that are used or investigated in epilepsy, most notably MRS. Results of MRS largely 
depend on determining a ROI in advance. However, even if there is a priory 
information, for example an identified epileptogenic lesion, the results of MRS and 
the conclusions based on these results are currently conflicting, especially in case of 
extra-temporal epilepsy. This may partly be due to the inhomogeneity of the 
populations studied, while the methods and protocols used also differed. In extra-
temporal epilepsy using MRS a decline of NAA concentration could be demonstrated 
in regions that were part of the epileptogenic or irritative zone (Guye 2005), according 
to intracerebral recordings. Six out of 12 patients in this study proved to have FCD at 
operation, 4 of them without abnormalities on conventional MRI, whereas 4 of the 12 
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patients were not operated upon. In another study in 12 out of 14 patients with frontal 
lobe epilepsy a decline of NAA concentration was seen in the epileptogenic focus 
(Lundbom 2001). According to structural MRI 4 had FCD (2 confirmed histological, 2 
statistically significant), whereas 7 showed no abnormalities. In mesiotemporal 
sclerosis (MTS) MRS can show abnormalities before conventional MRI does 
(Hammen 2003), and if bilateral hippocampal changes are found the prognosis of 
operation is less favorable (Lee 2005). In 15 out of 20 patients with a neocortical 
temporal lobe epilepsy without abnormalities on MRI Shih et al. (2004) found MRS 
abnormalities in the region predicted by MEG. In summary, there is increasing 
evidence that MRS may be more sensitive than structural MRI in detecting lesions. 
Most cryptogenic epilepsies are believed to arise from FCD (Bautista 2003). FCD has 
been recognised increasingly as one of the most common causes of 
pharmacoresistant focal epilepsy (Widders-Walsh 2006). FCD is a developmental 
disorder in which cytoarchitectural derangements occur. Abnormal, immature cells 
remain present accompanied by a disruption of normal cortical and subcortical 
architecture (Palmini 2004). As MRS is a sensitive measure of both neuronal 
maturation (Kok 2002; Kreis 2002; Tkac 2003) and neuronal dysfunction (Cendes 
1997; Tasch 1999) abnormalities are expected both in FCD and in epilepsy. As there 
is no support for a metabolic hemispheric asymmetry (Pouwels and Frahm 1998) 
when using MRS on patients their non-affected side can be used as control side in 
any given investigation. We investigated whether MRS-abnormalities in a focus as 
indicated by MEG in structural MRI negative epilepsy patients are comparable to 
MRS abnormalities in epilepsy patients with a FCD. Our goal was to determine 
whether SV-MRS could be supportive for localising an epileptogenic region and 
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eventually can be used in presurgical evaluation of epilepsy patients. This study is 
the first to do so for foci not confined to the temporal lobe. 
Methods 
All patients were outpatients of Epilepsy Centre Kempenhaeghe with localization 
related epilepsy. Two groups of patients were included in the study. In the first group 
(the FCD group) patients were included who on structural MRI had unilateral FCD. In 
group 2 (the MEG group) patients were included who already had an MEG-recording 
for another study (Colon 2009). Of these, patients in whom a plausible localization of 
the epileptiform activity within the grey matter could be determined using equivalent 
dipole modelling and in whom structural MRI showed no abnormalities were included. 
Exclusion criteria were the standard exclusion criteria for MRI investigations, a 
cerebral lesion on MRI that clearly was not FCD, inability to cooperate and age below 
18. In the FCD group 10 patients were included, in the MEG group 9. Patients age 
ranged from 21 to 73 years. 10 women and 9 men were included. Localization of the 
ROI is described in Table 1. Permission for this study was obtained by the Local 
Medical Ethical Committee and all patients signed the informed consent. 
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Age sexe EEG MRI location FCD 
1 44 m Left Left precentral sulcus 
2 53 m Left Left precentral sulcus 
3 22 m Right Right insula 
5 24 m Bilateral Left frontal 
6 32 f Left Left parietal 
7 39 m Left Left parietal 
8 22 f Left Left frontal 
10 44 f Left Left frontal 
11 24 m Normal Left occipital 
12 30 m Right Right frontal 
 
   
MEG 
20 21 m  Left peri-insular 
21 58 f  Left insular, 
Right lateral temporal 
22 52 f  Left angular 
23 59 f  Left mesial fronto-parietal 
24 73 f  Right temporo-occipital 
25 22 f  Left parietal 
26 34 m  Right temporal 
27 35 f  Left insula 
28 37 f  Right frontal 
Table 1: Patient Characteristics FCD (1-12) and MEG (20-28) group, Age in years. Sexe: m: male f: female. EEG: predominant 
side of found abnormalities on EEG. MRI location FCD: side and lobe. MEG: the location (side and lobe) of the irritative zone as 
provided by the result of the automated cluster- and localization analysis procedures applied to the interictal MEG spikes. 
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In order to get the best possible signal-to-noise ratio we decided to use single voxel 
1H-MRS (SV-MRS) and not chemical shift imaging (CSI). Even though CSI has the 
advantage of allowing a better spatial resolution and can be performed in a similar 
scan time as SV-MRS using SENSE parallel imaging, a CSI volume is more difficult 
to shim due to a larger shim volume. Better shimming provides smaller line widths 
and hence better SNR. SV-MRS spectra are therefor expected to be more robust, i.e. 
less variations over a large patient population. As there still is abundant discussion 
on the validity and on what reference to use of measuring absolute metabolite 
concentrations (Jansen 2006) we decided to express metabolite concentrations as 
peak ratios relative  to the creatine (Cr) peak, to calculate a lateralisation  index.  In 
both groups bilateral SV-MRS was applied and a lateralisation  index for the major 
metabolites was calculated. In all patients voxels of 1 cm×1cm×2 cm were placed. 
In the FCD group the location of the voxel was determined by the position of the 
FCD, including as much of the visible FCD as possible. In the MEG group the 
location of the voxel was determined by the source localization of clustered 
epileptiform activity in MEG (Ossenblok 2007). The contralateral voxel was placed 
over the corresponding gyri. We avoided inclusion of cerebro-spinal fluid (CSF) as 
much as possible, always less than 5% of the entire volume. MRI was performed with 
a 3 T Philips Intera MRI (Philips Healthcare, Best, The Netherlands). The MRI 
sequences consisted of 3D TFE in sagittal plane (TR 8.2 ms TE 3.7 ms, TI 1030 ms, 
flip angle 8, gap 0, resolution 1mm×1 mm), coronal FLAIR (TR 1100 ms, TE 128 ms, 
IR 2800 ms, 4.5mm slice thickness, gap −0.5) and two runs of 1H-MRS (one for each 
side) (TR 2000 ms, TE 37 ms, standard voxel size 1cm×1cm×2 cm, NSA 256). If at 
the initial quality control of the MRS sequence online the signal-to-noise ratio (SNR) 
of NAA was less than 5 or if the NAA, Cho and/or Cr peak could not be recognized, a 
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second run was performed. This was done either during the same session, only on 
the side where the problem appeared (n = 3), or double-sided on a separate session 
(n = 1). If a separate session was planned, the entire procedure was repeated. Post-
processing was performed using the standard Philips SpectroView software installed 
on the scanner. Initial baseline substraction was set using 15 terms in the polynomial. 
Automated peak fitting for NAA, Cho, Cr and Ins was applied. No corrections for 
relaxation were performed. Manual baseline correction was performed in Real 
modus. The NAA/Cr and the Cho/Cr ratios were calculated for each voxel. These 
data were used to calculate a lateralisation index (voxel ratio affected side/voxel ratio 
contralateral side). A Mann-Whitney test with a two-tailed p value was performed to 
analyse relevancy of the results. As this study was intended as a pilot study, we 
estimated the normal values setting at 1 with a SD of 0.1 in 10 persons 
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Results 
An example of the SV-MRI’s in one patient is shown in Fig. 1. 
    
A            B 
 
Figure 1: example of SV-MRS in one patient. Small MRI’s on top showing the positioning of the voxel. 
As this is a rectangle with fixed dimensions but positioned in slightly different ways to ensure 
comparible percentages of CSF shape and size seems to differ in different MRI-slices.  
MRS after baseline correction is depicted below including the peakfitting. A: affected side. B: healthy 
contralateral side 
 
In 7 out of the 10 patients in the FCD group and in 6 out of the 9 patients in the MEG 
group the NAA/Cr ratio was decreased on the affected side as compared to the 
contralateral side. This resulted in a mean lateralisation index of 0.772 (p = 0.01) in 
the FCD group and 0.845 (p = 0.04) in the MEG group. The difference between the 
FCD and the MEG group was not significant (p = 0.37). In the FCD group of 2 of the 
remaining 3 patients and in the MEG group of 3 of the remaining 3 patients it was not 
possible to determine the peak of the NAA, Cho and Cr reliably on both sides 
because of the low signal-to-noise ratio of the MR spectrogram. The Cho/Cr ratios 
were much more diverse without statistical significant difference in both groups (p = 
0.17 and 0.51 respectively) nor between both groups (p = 0.08). Results are shown in 
Table 2. 
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FCD group  side  NAA  Cho 
 
MEG group side NAA Cho 
1 le 0.818 0.998  20 le 0.975 0.842 
2 le 0.934 1.236  21  Noise  
3 ri 0.765 0.903  22 le 0.974 0.631 
5 le 1.084 0.929  23 le 0.629 1.366 
6 le 0.440 1.435  24 ri Noise  
7 le 0.872 2.107  25 le 0.831 0.897 
8 le Noise noise  26 ri Noise  
10 le 0.585 0.782  27 le 0.885 0.873 
11 le Noise 1.745  28 ri 0.778 1.182 
12 ri 0.681 2.457      
 
    
 
   
mean 
 0.772 1.399  mean  0.845 0.965 
SD 
 0.203 0.589  SD  0.132 0.264 
 
 
Table 2: MRS lateralisation indices in FCD and MEG groups 
Lateralisation index: (Metabolite/Cr affected side)/(metabolite/Cr contralateral side): ratio of 
“lesioned”/contralateral relative metabolite concentration. Side: le: left. Ri: right. Noise: SNR of at least 
one of the measured metabolites < 5 
 
Discussion 
Our main finding for all of the patients studied (n = 19) is a significantly decreased 
NAA/Cr ratio in the pathologic hemisphere as compared to the healthy side, whereas 
there is less consistency in the Cho/Cr ratios for both groups. We found no 
statistically significant differences between the FCD group and the MEG group. To 
our knowledge this is the only study published on MEG guided MRS findings in MRI 
negative patients including patients with extra-temporal foci. An earlier study by Shih 
et al. (2004) dealt only with temporal lobe patients. In addition we compared our SV-
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MRS data with SV-MRS data from patients with FCD visible at MRI. The present pilot 
study has limitations. Assessment of occurrence of seizures in the 24 h prior to the 
MRI was based on self-report. Therefor, we cannot be absolutely sure not to have 
recorded post-ictal changes. However, in the context of a pilot study it was not 
acceptable to hospitalize the patients 24 h prior to the MRI. Furthermore, even 
though Simister et al. (2007) found 1H-MRS to be sensitive to metabolite changes 
following epileptic seizures within the immediate post-ictal period the individual NAAt 
and NAAt/Cr levels did not change significantly between studies directly post-ictal as 
compared to 7 h post-ictal. We did not correct for age even though it is shown that 
concentrations and ratios change with age (Angelie 2001). We compared ipsi and 
contra lateral side in the same patient. As far as we could investigate patients have 
had no other brain injuries or diseases. Concentration changes due to aging are 
presumed to be symmetrical. Therefor, any asymmetry can be attributed to the 
epilepsy or the FCD. Concentrations of Cr are more or less equal in all brain regions 
including ‘‘epileptic’’ brain tissue and are stable, even in epilepsy (Peeling, 1992; 
Peeling and Sutherland 1993; Kauppinen and Williams 1994; Cross 1996; Cendes 
1997). There are also indications that Cr concentration in grey matter is higher than 
in white matter (Pouwels and Frahm 1998). Furthermore, cerebrospinal fluid (CSF) is 
considered to provide negligible signal (Lynch 1993). Unfortunately, at present we 
are not able to perform segmentation on single voxel MRS data. While placing the 
voxels we took care to include as equal as possible amounts of all three components 
in each voxel within the same patient. Positioning of a voxel over the MEG indicated 
region means that most of the time the voxel is placed very close to the convexity of 
the brain. Closer to the convexity, however, it is more likely that there is an effect of 
the skull on the SV-MRS resulting in a lower SNR. Therefor, the gain of using a 
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single voxel instead of CSI could be lost again. In our MEG-group, despite a second 
recording (but not a third) we did not succeed in getting a reliable MRS-spectrum on 
both sides in 3 out of 9 patients. In FCD this is less of a problem as most in our group 
have a tail going from the dysplasia to the ventricle, allowing for a less lateralised 
positioning of the voxel. We choose to use the ratios to Cr as our standard. 
Quantitative analysis of concentration would give a better insight. There is, however, 
still too much uncertainty about the viability of the different methods of quantitative 
analysis (Jansen 2006). We therefor decided against using these methods at this 
stage. It is likely that results of SV-MRS in epilepsy patients will have a normal 
distribution. If this is so, the use of an unpaired t-test would be appropriate in this 
study, resulting in more outspoken significance levels. However, as our sample size 
is too small to prove a Gaussian distribution we decided to use the Mann—Whitney 
test, also resulting in significant results. It has been reported that in patients with 
temporal lobe epilepsy the temporal MRS spectrum ipsilateral to the seizure focus 
displays a significant increase in total Cr (and also Cho) (Connelly 1994). Similar 
conclusions were drawn in studies on frontal lobe epilepsy (Lundbom 2001). NAA 
concentration is considered to be a rather nonspecific marker of neuroaxonal integrity 
and is decreased in a wide range of diseases (Bizzi 2005). Combining these data the 
NAA/Cr ratio on the affected site is expected to decrease dramatically in epileptic 
patients. However, we found only a modest decrease in NAA/Cr lateralisation index. 
Our data does not support the aforementioned ipsilateral versus unilateral Cr 
decrease. Although we found a decreased lateralisation index in NAA/Cr ratio in the 
region of the FCD, which is in agreement with the findings of Munakata et al. (2003), 
the decrease is less pronounced than the decreases found by Munakata et al. A 
reason might be the distinct references used. Munakata et al. used a remote part of 
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the contralateral cortex. As there are regional differences we decided to use for 
control the homologue contralateral cortex. Even although we thoroughly screened 
for other regions displaying cortical dysplasia in our patients there might have been 
contralateral FCD below detection threshold. This statement, however, is highly 
speculative. Furthermore, none of the patients included in this study was recruited 
from the presurgical group, in order not to give them any false hope. We expect the 
differences found to be more outspoken in presurgical patients, because our patient 
group includes less severe epilepsies than in the presurgical group. The lower 
NAA/Cr ratio on the location where MEG predicts an epileptogenic lesion provides 
extra support for the localization of the epileptogenic focus. However, it does not 
prove there is FCD at the investigated region. Our findings do agree with an earlier 
study on metabolic disturbances in epileptic patients without MRI abnormalities 
and/or with a focal lesion (Lundbom 2001). It is an indication that there is neuronal 
damage in that region. Bearing in mind that metabolite changes in FCD are evidently 
less pronounced than in low grade gliomas (Vuori 2004), combined with the fact that 
there were no significant differences in lateralisation index profile in the FCD and 
MEG group it is appealing to postulate that our findings in MRI negative patients 
could suggest the presence of FCD. Further study of this method in MRI-negative 
patients in the presurgical evaluation will be carried out and will provide us with a 
correlation with a histopathological substrate. However, MEG guided SV 1HMRS 
does seem to be helpful in determining the presence of an epileptogenic focus. 
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Chapter 4.2  
3T versus 7T 
4.2.1 FCD 
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Detection superiority of 7T MRI protocol in patients 
with epilepsy and suspected focal cortical 
dysplasia. 
 
A.J. Colon, M.J.P. van Osch, M. Buijs, J. v.d. Grond, P. Boon, M.A. van Buchem, 
P.A.M. Hofman 
(Acta Neurol Belg. 2016;116(3):259-269  ) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Acknowledgement: The authors wish to thank G.L. Wagner, neurologist and J.C. 
Beckervordersandforth and E. Aronica, neuropathologists, for their support. 
84 
 
 
Abstract 
In 11 adult patients with suspicion of Focal cortical dysplasia (FCD) on 1.5T (n=1) or 
3T (n=10) magnetic resonance imaging (MRI), 7T MRI was performed. Visibility, 
extent, morphological features and delineation were independently rated and 
subsequently discussed by three observers. Additionally, head-to-head comparisons 
with corresponding 3T images were made in the eight patients with a previous 3T 
MRI and sustained suspicion of FCD. Comparison with histopathology was done in 
the five patients that underwent surgery. All lesions, seen at 1.5T and 3T, were also 
recognized on 7T. At 7T FLAIR highlighted the FCD-like lesions best, whereas T2 
and T2* were deemed better suited to review structure and extent of the lesion. 
Image quality with the used 7T MRI setup was higher than the quality with the used 
3T MRI setup. In 2 out of ten patients diagnosis changed, in one after re-evaluation 
of the images,  and in the other based on histopathology. 
With the used 7T MRI setup, FCD-like lesions can be detected with more confidence 
and detail as compared to lower field strength. However, concordance between 
radiologic diagnosis and final diagnosis seems to be lower than expected. 
 
 
 
Keywords: 7T MRI, Focal Cortical Dysplasia, Epilepsy, human, misdiagnosis 
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 Introduction 
20-40% of epilepsy patients are drug resistant. In this group resective surgery, if 
possible, is the treatment of choice [Cockerell 1995, Kwan 2000]. Finding a lesion on 
Magnetic Resonance Imaging (MRI) is of clinical importance, as presence of a lesion 
is associated with a higher chance of developing drug resistant (refractory) epilepsy 
[Yoon 2011] and increased success rate of surgery [Bien 2009, Oster 2012, Rowland 
2012]. Sensitivity of MRI for brain lesions partly depends on the system’s magnetic 
field strength [Von Oertzen 2002, Knake 2005, Phal 2008, Strandberg 2008, Mellerio 
2014, Tselikas 2015]. Higher field strength gives rise to higher signal-to-noise ratio, 
which allows for higher anatomical resolution and increased sensitivity for contrast 
mechanisms such as those based on iron [Li 2006, Kwan 2012, Fukunaga 2010, 
Conijn 2011, Yao 2012, Van Veluw 2013]. Most studies in epilepsy patients have 
been performed using 1.5 and 3T MRI systems. MRI systems operating at a 
magnetic field strength of 7T may have added value for epilepsy patients [Breyer 
2010] especially because they may have a higher sensitivity for focal cortical 
dysplasia (FCD) and decrease the number of MRI-occult FCDs. In surgical series, 
FCD is a common pathologic finding with a reported presence in 8% [Alexiou 2009] 
to 53% of the operated epileptic patients [Piao 2010]. 20-30% of patients with 
postsurgical proven FCD were MRI-negative [Tassi 2002, Krsek 2008, Yoon 2011]. 
No systematic comparison between 3T MRI and 7T MRI appearance of FCD is 
available. On the other hand, MRI diagnosis of FCD can be erroneous. FCD’s can be 
hard to distinguish from gliomas, with a preference for FCD on frontal locations or a 
lesser distinct high intensity on T2 weighted images than in case of glioma [Abdel 
Razek 2009]. 
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The most frequently described MRI features of FCD include: increased cortical 
thickness, blurred grey/white matter junction, increased signal on T2, decreased 
signal on T1 of the subcortical white matter and gyration anomalies [Tassi 2002, 
Krsek 2008]. The most typical feature highly specific for FCD type II is alteration of 
white matter signal towards the ventricle, the “transmantle sign” [Colombo 2012]. 
Presence of a focal lesion (e.g. mesiotemporal sclerosis) combined with FCD defines 
FCD type III. FCD can be characterised by combinations of several of the above 
mentioned MRI features [Blümcke 2011]. In many patients only a subset of these 
MRI features are detected [Blümcke 2011].  
As presentation of an abnormality can be dependent on the field strength, we wanted 
to study the presentation on 7T MRI of FCD’s previously described on lower field 
strength MRI. Furthermore findings on 3T MRI if available were compared to the 
appearance at 7T MRI and radiologic diagnosis was compared to histopathology in 
operated cases. 
  
Methods 
Ten adult patients, diagnosed with localization related epilepsy and presence of a 
lesion diagnosed as FCD on 3T (n=9) or 1.5T (n=1) MRI, were included (patient 
characteristics: table 1). An additional patient (Patient 5) was excluded from further 
analysis as due to technical failure on 7T MRI the signal-to-noise ratio was too low. 
All lesions were located extra-temporal, one with temporal extension and one with 
dual pathology. Standard MRI exclusion criteria were applied. Presence of a dental 
retainer wire was added as a 7T-specific MRI exclusion criterion. At present this is 
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not an exclusion criterion any more [Wezel 2014]. Informed consent was obtained 
from all individual participants included in the study. The study was approved by the 
Institutional Review Board of LUMC (Leiden Universitair Medisch Centrum). 
 
 
patient age sexe Location of FCD  
on previous MRI 
semiology 
1 34 M Right frontal Conscious, forced head version to right  followed by 
secondary generalisation 
2 22 M Left parietal Short lasting: Iight headedness, goosebumps, staring, 
incorrect answers, bilateral manual automatisms 
3 25 V left frontal Stretching right arm and inability to speak 
4 44 M Left temporo-occipital Lowered consciousness, automatisms, wandering 
5 47 M Left parietal Nightly symmetric or asymmetric tonic contractions or very 
brief myoclonias 
6 21 M Right parietal Visual hallucinations, lowered consciousness, hypermotor 
behaviour 
7 47 V Right hand knob Pounding sensation left thumb, painfull contraction left 
hand 
8 20 M Left occipital Sensation of mouth movement, inability to speak, 
problems with co-ordination. If secondary generalisation 
then post-ictal visual disturbances 
9 34 M Left parietal Vibrating sensation right face, sensation of falling to the 
right (actually going to the left), raising right arm, staring. 
Fully conscious. 
10 36 V Left parietal 1) Sensation of jaw cramp, tingeling gums, 
hypersalivation, aphasia 
2) short epigastric aura, tonic contraction right arm, 
secondary generalisation 
11 43 V Right frontal 1) cephalic sensation, fear, sensation of short of breath 
2) during sleep head turning to left, orofacial automatisms 
and/or bipedaling and/or hypertonia left arm 
Table 1: Patient characteristics of patients with signs of FCD on prior MRI.  
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7T MRI was performed on a Philips Achieva platform (Philips Healthcare, Cleveland, 
Ohio) using a 32 channel receive head coil with quadrature transmit. The following 
sequences were used: 3D T1 (TR 4.2 ms, TE 1.88 ms, voxel-size 0.9x0.9x0.9mm), 
3D FLAIR (TR 7900 ms, TE 300 ms, TI 2200 ms, voxel-size 0.85x0.85x0.85mm), T2 
TSE (TR 3000 ms, TE 58 ms, voxel-size 0.5x0.5x1mm) and T2* (TR 1764 ms, TE 
25ms, voxel-size 0.24x0.24x1 mm). Total acquisition time was under one hour, which 
was considered acceptable for possible future use in clinical practice. The 3T MRI 
images were acquired using a 16 channel receive head coil and a state-of-the-art 
epilepsy protocol (3D-T1 (TR 8.1 ms, TE 3.7 ms, voxel  1x1x1 mm), T2 (TR 3000 ms, 
TE 80 ms, voxel  0.5x0.5x5 mm), T2* in the last 5 patients (TR 777 ms, TE 16 ms, 
voxel 0.9x1.1x5 mm), IR (TR 120 ms, TE 10 ms, TI 400 ms, voxel  0.4x0.6x2 mm), 
FLAIR (TR 8000 ms, TE 50 ms, TI 2400 ms, voxel  1.1x1.1x0.5 mm)) performed on a 
Philips 3.0T Achieva platform  (Philips Medical systems, Best, Netherlands). 
Diagnosis of FCD was made by an experienced neuroradiologist in a tertiary epilepsy 
centre (PH). In one patient only 1.5T MRI, made in a referring hospital, was available; 
since this 1.5T MRI examination showed clearly an FCD, additional 3T MRI was 
deemed unnecessary. 
 
Patient charts were examined by two neurologists (AC, LW), with experience in 
analysing patients for epilepsy surgery. Based on medical history, semiology, EEG, 
and if available seizure-recordings clinical estimation of the location of the 
epileptogenic focus was formulated. If the patient underwent surgery data on 
histopathology were noted. Data were compared to the MRI results. 
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Two experienced neuroradiologists (MvB, PH) and a neurologist (AC) visually 
inspected the images.  
 
All observers were aware of the presence of a MRI-detectable lesion. Windowing was 
individually adapted to gain optimal contrast. Orientation of slides with the highest 
visibility of the abnormality was chosen separately for each field strength. Presence 
and characteristics of a possible FCD (see table 2) were noted using a predefined 
scoring system. Seven features were scored: blurring of the grey-white matter 
junction, focal thickening of the cortex, focal increased intensity, presence of a 
transmantle sign, clear demarcation of transition to normal cortex, gyral pattern and 
abnormal Internal structure. A flag-like appearance of the FCD was noted in several 
patients This characteristic was added to the study. 
In 8 patients with a 3T MRI and a sustained pre-operatieve diagnosis of FCD the 
features of the FCD on T2 and FLAIR images were rated for visibility using a Likert 
scale from 1 to 3 [Likert 1932]: 1 indicating 7T superior to 3T, 2 equal quality, and 3 
indicating 3T superior to 7T. Comparison was made between the same sequences 
using a Sign test (http://www.fon.hum.uva.nl/Service/Statistics/Sign_Test.html). Non-
difference was set as the null hypothesis. As T2* was not available in all 3T MRIs no 
comparison between T2* on 7T and on 3T sequence was made. 
 
Results 
In none of the patients abnormalities were found on 7T MRI that were not observed 
at lower field strength and all lesions visible at lower field strength were visible at 7T. 
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In the ten analysed patients, both neurologists agreed that the stereotyped seizures 
were based on a single epileptogenic focus. In each patient one or more hypotheses 
on the possible locations of this epileptogenic focus could be postulated. Comparison 
between these hypotheses and the location of the lesion on MRI showed 
concordance in each individual patient. 
 By visual inspection in all patients the lesion was detected on 7T MRI without prior 
knowledge of the location as seen at lower field strength. In patient 1 the diagnosis 
changed from FCD to cavernoma based on the 7T MRI and re-evaluation of the 3T 
images. The treating physician was informed. Further visual analysis of the 7T MRI 
was done for the remaining nine patients.  
On the T1-weighted images cortical thickening and blurring were most prominent 
(figure 1). A hypo-intense line at the grey-white matter junction was observed on T2 
weighted images (figure 2) in eight patients creating a typical three layer flag-like 
appearance. Detection of the FCD was readily made on the FLAIR images (figure 3), 
whereas the abnormal internal structure of FCDs was most clearly seen on T2* 
(figure 4). Of the seven imaging features, four (blurring of grey-white matter, focal 
signal increase, visibility of transition to normal cortex, abnormal internal structure) 
were observed in all nine patients. Focal thickening was observed in eight patients, 
funnel shaped extension in and the presence of an abnormal gyral pattern in six 
 patients (table 2). The flag-like appearance was noted in all but patient 3. 
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Fig. 1  
7 T T1 image showing cortical thickening and blurring 
 
Fig. 2  
7 T T2 image showing cortical thickning, transmantle sign (left) and flag-like 
appearence at the bottom of the sulcus in FCD (right more pronounced than left) 
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Fig. 3  
7 T FLAIR image, showing highlighted FCD 
 
Fig. 4  
7 T T2* image showing abnormal internal structure of FCD 
93 
 
Patient 2 3 4 6 7 8 9 10 11 Overall 
Blurring + + + + + + + + + 9/9 
Focal thickening  + + + + - + + + + 8/9 
Focal increased 
intensity 
+ + + + + + + + + 9/9 
Transmantle sign - + - - + + + + + 6/9 
Transition to normal 
cortex 
v s s s v s s s s 2 vague, 7 sharp 
Gyral pattern norm abn abn abn norm norm abn abn abn 6/9 
Abnormal Internal 
structure 
+ + + + + + + + + 9/9 
Total 4/7 7/7 6/7 6/7 4/7 6/7 7/7 7/7 7/7  
Table 2: features of FCD recognized on 7T MRI, all sequences combined. +=present, -=not visible, v=vague, s=scharp, 
norm=normal, abn=abnormal 
In the eight patients in whom 3T MRI was available, 7T MRI depiction scored 
significantly better than 3T MRI for blurring (p<0.01), abnormalities of internal 
structure (p<0.01) and demarcation of transition to normal cortex (p<0.02) (figure 5) 
on T2 and for abnormalities of internal structure (p<0.04) on FLAIR.  
Although not statistically significant, 7T MRI tended to be superior to 3T on another 7 
out of 14 scored items (2 sequences compared, with 7 features analysed in each 
comparison) 3T MRI tended to be superior to 7T on none of the 14 items (table 3). 
When combining all 7 analysed characteristics on T2 and FLAIR in each individual 
patient, 7T scored better than 3T (table 4).  
94 
 
     
 
       
Figure 5 a: comparison between T2 weighted  3 (top) and 7 (bottom) T images of a patient with known FCD right hand knob to 
deep-of-the-sulcus 
 
     
 
 
Fig. 5 b . same patient: comparison between FLAIR  3 (left) and 7 (right) T images of a patient with known FCD right hand knob 
to deep-of-the-sulcus  
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Table 3 : Conventional Visual Analysis of 3 vs 7 T images. 
Blue: 7T superior to 3T. Red: 7T and 3T equal. Green: 3T superior to 7T. Purple: feature not visible. 
Last column: p-values Sign Test, significant values in fat. 
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Patient 2 3 4 6 7 8 10 11 7T better:3T better 
Blurring T2 1 1 1 1 1 1 1 1  8/8:0/8 
Focal 
thickening T2 
Na 0 1 1 Na 1 1 0  4/6 :0/6 (na :2) 
Focal increased 
intensity T2 
1 0 1 1 1 0 0 -1  4/8:1/8 
Transmantle 
sign T2 
Na 0 Na Na Na 0 1 1  2/4:0/4 (na: 4) 
Transition to 
normal cortex 
T2 
1 1 1 1 1 1 1 0  7/8:0/8 
Gyral pattern 
T2 
Na Na 1 1 Na Na Na Na  2/2 (na: 6) 
Internal 
structure T2 
1 1 1 1 1 1 1 1  8/8:0/8  
Blurring FLAIR -1 0 1 1 1 1 1 1  6/8:1/8 
Focal 
thickening 
FLAIR 
Na 0 1 1 Na 1 0 0  3/6:0/6 (na: 2) 
Focal increased 
intensity FLAIR 
-1 0 1 1 1 1 1 0  5/8:1/8 
Transmantle 
sign FLAIR 
Na 1 Na Na 0 0 1 1  3/5:0/5 (na: 3) 
Transition to 
normal cortex 
FLAIR 
-1 1 1 1 1 1 1 W 7T,  
G 3T 
(1) 
 6*/8:1*/8 
Gyral pattern 
FLAIR 
Na Na 1 1 Na Na Na na  2/2 :0/2 (na: 6) 
Internal 
structure FLAIR 
na Na 1 1 1 1 1 1  6/6 :0/6 (na: 2) 
Total 7T better 
than 3T 
4/7 5/11 12/12 12/12 8/9 9/12 10/12 6/11*  
Total 3T better 
than 7T 
3/7 0/11 0/12 0/12 0/9 0/12 0/12 1/11*  
Total not 
applicable 
7 3 2 2 5 2 2 2*   
Table 4: comparison between 3T and 7T MRI’s combining all characteristic on T2 and FLAIR. -1: 3T 
better than 7T, 0: equaly visible on 3T and 7T, 1: 7T better than 3T, na: Not applicable as not visible 
on either 7T or 3T, W: white matter, G: gray matter. *: excluding patient 11 transition to normal cortex 
on FLAIR  
 
 
Five of the six included patients that were also evaluated for epilepsy surgery were 
operated. In patient 3 histopathology showed a ganglioglioma WHO grade 1, patient 
8 had FCD type IIIb (frontal infantile desmoplastic ganglioglioma with bordering FCD 
operated plus parietal FCD that we analysed in this study), patient 9 showed a FCD 
type IIa and patients 10 and 11 showed a FCD type IIb. The location of the lesion 
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was congruent between MRI and surgical specimen. The 3T MRI and 7T MRI images 
of the 2 patients in whom the diagnosis changed from FCD to respectively 
cavernoma and ganglioglioma are shown in figure 6. 
One patient complained of profound nausea at entering the MRI. Slowing down the 
table movement reduced the symptoms. During the imaging this complaint was not 
present. 
 
Discussion 
The main finding of this study is that all observers agreed that on conventional visual 
analysis the lesions were easier detected and better detailed with the applied 7T MRI 
protocol than on lower field strength. None of the known lesions were missed on the 
7T images. Using a semi-quantitative scale, overall our 7T MRI protocol tended to be 
superior to the previously applied 3T protocol. Statistical significance was reached for 
4 out of 14 scored items. In two patients final diagnosis changed from FCD to 
respectively cavernoma and gangioglioma 
As far as we know this is the first publication describing 7T MRI in a group of patients 
with suspicion of FCD using a standard clinical protocol.  
In one patient, due to the 7T images diagnosis changed from FCD to cavernoma. 
There are several explanations possible for this change. First, due to slice thickness 
in the 3T images the small hemosiderin deposit could have been located exactly in 
between 2 slices, thus escaping detection. Due to the thinner slice thickness of the 
7T images, the hemosiderin is more obvious. The images as depicted in figure 6 
seems to substantiate this hypothesis. Second, the artefact effect of hemosiderin is 
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more pronounced on 7T MRI than on 3T MRI, thereby highlighting the cavernoma 
more evidently in 7T MRI. The sequence most sensitive for hemosiderin is SWI 
(susceptibility weighted imaging). However, in epilepsy the presence of small 
hemosiderin deposits is of minor relevance and therefor in the initial phase of our 
study this swquence was not part of our standard epilepsy protocol. This will have 
lowered the sensitivity for the detection of small haemorrhages on the 3T MRI more 
than the sensitivity of 7T MRI. Especially compared to 7T MRI, in which a T2* 
weighted sequence was part of the standard protocol. Third, there is a time delay of 
several months between these 3T and 7T MRI’s. Although there were no additional 
clinical symptoms, it is possible that in between these time points the amount of 
blood surrounding the cavernoma increased. As the patient is no longer under our 
care we regrettably do not have access to a 3T MRI made after the 7T MRI.  
In one of the five operated cases histopathology showed that the abnormality was a 
ganglioglioma instead of a FCD type II as the radiological diagnosis stated. Re-
challenging of three pathologists and two radiologists with information on the opinion 
of the other specialist did not change their conclusions. Taking the diagnosis of the 
pathologists as gold standard, this proves that MRI can help giving an indication of 
the diagnosis. But visual inspection is not (yet) able to provide the definite diagnosis 
with 100% certainty. Noteworthy is the fact that in this patient (patient 3) all evaluated 
MRI-characteristics of FCD were present, including a transmantle sign (fig 6). 
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Fig 6: changed diagnoses from original (FCD) to ganglioma.  left: 3T MRI. right: 7T MRI.  
The frequency of the imaging features of FCDs as seen in our study is higher than 
reported for FCD in the literature for 1.5T and 3T studies. For example cortical 
thickening was seen in 50% [Krsek 2009] to 76% [Lerner 2009] whereas in our series 
it is 89%. Blurring ranged from 36% [Urbach 2002] to 87% [Colombo 2003], whereas 
in our series it is 100%. For transmantle sign this ranged from 19% [Besson 2008] to 
81% [Urbach 2002], and in our series it is 67%. Most publications are based on 
histopathologically proven diagnoses of FCD, including patients without MRI 
abnormalities, whereas for our study the suspicion of a FCD on lower field strength 
MRI was an inclusion criterion. This explains the relative high frequency of the 
imaging features in our series. Quality of the 7T MRI images itself plays a role as 
well: signal-to-noise ratio scales approximately linear with magnetic field strength 
[Van der Kolk 2012, Versluis 2012]. Furthermore, it has also been observed that 7T 
MRI provides an increased contrast-to-noise ratio in FLAIR as compared to 1.5T and 
3T [Li 2006, Zwanenburg 2010]. The smaller voxels that can be achieved with 7T 
MRI within a clinically applicable protocol will also provide better spatial resolution, 
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leading to the detection of thin abnormalities, such as blurring or the transmantle 
sign.  
Other limitations of the current studies include the fact that, besides the magnetic 
field strength, the scanners differed with respect to other hardware such as the 
number of receive channels of the head-coil and that choices of sequence 
parameters were based on local expertise without an effort to homogenize these 
between the field strengths. Comparisons were made between acquisitions made on 
the scanners available to us, which led to inherent differences in receive and transmit 
coil properties, other hardware components as well as software. Using, for example, 
a 32-channel head coil for the 3 T might have improved image quality on that field 
strength. However, based on our experience with both field strengths we think that 
magnetic field strength is the main contributor to the improved image quality. 
 
Applying visual analysis, in our series 7T MRI FLAIR was the sequence on which the 
lesions were most prominent. The flag-like three-layer appearance is easiest 
appreciated on T2. The middle hypo-intense line is accentuated by the bordering 
hyper-intense parts of the lesions. However, even though much less pronounced, 
looking at the homologue contralateral area this line often is bilaterally noticeable. 
The appearance of this line is not equally distributed in all different regions, which is 
in line with the findings of Zwanenburg et al [2012] who described similar regional 
differences (but no asymmetries) in the normal brain in 7T MRI. The line is located at 
the grey-white matter junction and is present in almost all regions, and therefor it 
does not represent the striae of Gennari [Gennari 1782]. Based on our small series, 
this line seems to be more prominent with rising age, even more in the FCD-like 
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region than in the other regions of the brain. We postulate that this line represents 
iron deposits which would explain an age-dependency [Hagemeier 2012]. 
Alternatively, this line could represent a low signal coming from the deepest cortical 
layer, seen on thin 7T slices but masked on thicker 3T slices. In 7T MRI this 
accentuated three-layer appearance on the T2 weighted images has the potential to 
be used as an imaging marker of FCD. The internal structure and extend of the 
lesions were best visible on T2 and especially T2* sequences. This is in line with 
expectations, as the T2* sequence provides high spatial resolution and sensitivity to 
the magnetic susceptibility properties of tissues, thus improving evaluation of the 
different components within the cortex. When in more cases histopathology will 
become available, this might help in differentiating between different pathological 
substrates, like the different types of FCD.  
 
Although due to the nature of this study we did not co-register all the sequences of 
3T and 7T study, visual inspection and interpretation support the notion that on 7T 
the lesion seemed often to extends beyond what is seen on 3T.  
Because of the better delineation of lesions on 7T, if intracranial EEG recording is 
needed we would advise to use the T2 sequence to guide the implantation. 
Especially in case of multiple depth-electrodes (Stereo-EEG) where presurgical 
delineation of the abnormality is even more dependant on electrode placing than 
when using grids.  
 
In epilepsy, abnormalities observed on MRI do not always reflect the epileptogenic 
focus. This is illustrated by the observation of Salmenpera et al [2007] that 9% of 3T 
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MRI-positive findings are not related to the epileptogenic lesion. Therefor, every 
positive MRI result should be interpreted with caution and in combination with the 
electro clinical findings. However, clinical assessment based on the intra-individual 
stereotyped semiology makes it likely that all our patients had a single epileptogenic 
focus, correlating well with the observed location of the lesion. Interpretation of MRI 
should only be done including all clinical information available. This holds true for all 
other modalities such as PET, MEG and intracranial EEG as well. Probably, 
multimodality fusion will increase insight in analysing difficult surgery cases. The 
limitation of our study is that we included only patients with a diagnosis of FCD based 
on 3T or 1.5T MRI and only three patients had a histologically proven diagnosis. 
Further studies will evaluate the additional value of 7T MRI in presurgical analysis in 
patients without abnormalities on 3T MRI. There is one study on the detectability of 
FCD’s on 7T MRI in 21 patients without lesions on 3T or 1.5T MRI, showing a 29% 
diagnostic gain [De Ciantis 2016]. Agreement in imaging interpretation was reached 
through consensus-based discussions based on visual identification of structural 
abnormalities. Four out of the 6 patients with a thus detected lesion were operated, 
all showing a FCD on histopathology. These results are almost identical to our own 
results [Colon 2016]. 
 
Conclusion 
7T brain imaging in vivo is feasible in epilepsy patients and can be beneficial. 
Lesions are well recognizable and details are better visible than at lower field 
strengths. The presence of typical FCD-characteristics on MRI, however, does not 
always reflect the final histopathological diagnosis.  
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4.2.2 MEG-guided 7T MRI in 3T MRI negative patients 
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Abstract 
 
Aim: To study possible detection of structural abnormalities on 7T MRI that were not 
detected on 3T MRI and estimate the added value of MEG-guidance. For 
abnormalities found, analysis of convergence between clinical, MEG and 7T MRI 
localization of suspected epileptogenic foci. 
Methods: In adult patients with well-documented localization-related epilepsy in 
whom a previous 3T MRI did not demonstrate an epileptogenic lesion but MEG 
indicated a plausible epileptogenic focus, 7T MRI was performed. Based on 
semiologic data, visual analysis of the 7T images was performed as well as based on 
prior MEG results. Correlation with other data from the patient charts, for as far as 
these were available, was analysed. To establish the level of concordance between 
the three observers the generalized or Fleiss kappa was calculated. 
Results: In 3/19 patients abnormalities that, based on semiology, could plausibly 
represent an epileptogenic lesion were detected using 7T MRI. In an additional 3/19 
an abnormality was detected after MEG-guidance. However, in these later cases 
there was no concordance among the three observers with regard to the presence of 
a structural abnormality. In one of these three cases intracranial recording was 
performed, proving the possible abnormality on 7T MRI to be the epileptogenic focus. 
Conclusions: In 32% of patients 7T MRI showed abnormalities that could indicate an 
epileptogenic lesion whereas previous 3T MRI did not, especially when visual 
inspection was guided by the presence of focal interictal MEG abnormalities. 
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INTRODUCTION 
Epilepsy has an estimated prevalence of 0.4 to 1.4% (WHO 2015). At least 61% of 
the patients diagnosed with epilepsy suffer from localization-related epilepsies 
(Browne 2000). Approximately 30% of patients with localization-related seizures 
suffer from refractory epilepsy (Kwan and Brodie 2000). In up to 74% of patients with 
localization-related seizures, MRI shows no abnormalities (Griffiths et al 2005). In 
children with epilepsy this is about one-third (Reijs et al 2007). Prognosis for seizure 
control following focal resection of the epileptogenic zone is excellent (Urbach et al 
2002). Identification of a lesion on MRI is a major predictive factor for surgical 
outcome (Yun et al 2006, Noe et al 2013). The majority of patients suffering from 
focal seizures of unknown origin (Berg et al 2010) probably have a small focal cortical 
dysplasia (FCD) (Bautista et al 2003, Barkovich et al 2005). FCD’s often escape 
detection with present imaging techniques (Wang et al 2014), may considerably vary 
in size and localization (Guerinni et al 2008) and are likely to be located at the bottom 
of sulci (Besson et al 2008). Using higher field strength MRI more abnormalities can 
be visualized (Von Oetzen  et al 2002, Phal et al 2008). Therefor, 7 T MRI yields the 
promise of improving detection. In epilepsy patients, ex vivo (Zucca et al 2016) and in 
vivo 7T MRI examples of FCD in humans are available (De Ciantis et al 2016, Colon 
et al 2016, Veersema et al 2016). 
When an MRI is re-analysed with an a-priori hypothesis more lesions are detected 
(Moore et al 2002, Itabashi et al 2014). Magnetoencephalography (MEG) is not only 
a reliable indicator of epilepsy (Colon 2016) but also a powerful tool to determine a 
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possible epileptogenic focus (Ossenblok 2007, Kharkara 2015) and is of growing 
presurgical importance in combination with MRI (MRS, magnetic source imaging) 
(Bagić 2016).  
The present study explores the possible role of visual and of MEG-guided visual 7T 
MRI analysis in improving detection of a possible epileptogenic lesion. The levels of 
convergence between clinical data, MEG and 7T MRI findings are described. 
 
Methods 
Patients were prospectively recruited from the Academic Centre for Epileptology 
(ACE), location Kempenhaeghe, a tertiary epilepsy centre. Additionally, two patients 
were referred by another institution (SEIN) to participate in this study. Inclusion 
criteria included previously diagnosed focal epilepsy, MEG results showing 
epileptiform abnormalities concordant with semiology (“plausible”), and a 3T-MRI 
without showing abnormalities that could explain the seizures, despite availability of 
all other clinical data. Further inclusion criteria included age 18 or above and signed 
informed consent. Exclusion criteria included pregnancy and being incapacitated. 
Standard MRI-exclusion criteria applied, including body implants that are not (yet) 
proven safe at 7T MRI.  
Although not an inclusion criterion, all but one patient were included during a period 
of pre-surgical analysis. Seizure description, MEG results and other auxiliary 
information on possible locations of the epileptic focus were gathered from the patient 
charts. If, after analysis of the 7T MRI, a patient was operated upon, data on results 
of surgery and histopathology were added to the database. The 7T MRI then was re-
evaluated by two of the three observers. 
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Previously performed clinical MEG data (Neuromag 306, Elekta Oy, Helsinki, 
Finland) had been analysed in an experienced centre (VUmc, Amsterdam, 
Netherlands) and indicated a plausible epileptogenic focus in all patients. MEG 
recording time was at least one hour, including eye opening and closing, 
hyperventilation and rest. Obtaining a recording in sleep was not mandatory. No EEG 
co-registration was available. Used analysis methods included equivalent current 
dipole modelling and beamforming analysis. (Baillet 2001, Klink 2016) 
The previously performed  state-of-the-art 3T MRI (3.0 T Achieva, Philips, Best, The 
Netherlands) was analysed by an experienced neuroradiologist with special interest 
in epilepsy, aware of all available data including the MEG results. A voxel-based 
morphologic analysis program (MAP-07 (Huppertz et al 2008, Wang et al 2015)) was 
available during part of our study. During this time, patients were only included if 
MAP-07 did not indicate any abnormalities. In 14 out of the 19 included patients 
MAP-07 was applied. Used 3T MRI sequences included 3D-T1 (TR 8.1 ms, TE 3.7 
ms, voxel  1x1x1 mm), T2 (TR 3000 ms, TE 80 ms, voxel 0.5x0.5x5 mm), T2* (TR 
777 ms, TE 16 ms, voxel 0.9x1.1x5 mm), IR (TR 120 ms, TE 10 ms, TI 400 ms, voxel 
0.4x0.6x2 mm) and FLAIR (TR 8000 ms, TE 50 ms, TI 2400 ms, voxel 1.1x1.1x0.5 
mm) No abnormalities that could account for the particular epilepsy were found.  
7T MRI was applied well within the limits of the American Food and Drug 
Administration (FDA) guidelines. Images were acquired on a Philips 7.0 T Achieva 
(Philips, Best, The Netherlands) using a 32-channel receive head coil at Leiden 
University Medical Center (LUMC). The protocol included: 3D T1 (TR 4.2 ms, TE 
1.88 ms, voxel 0.9x0.9x0.9mm), 3D FLAIR (TR 8000 ms, TE 300 ms, TI 2200 ms, 
voxel 0.80x0.84x0.80mm), T2TSE (TR 3000 ms, TE 58 ms, voxel 0.5x0.5x1mm) and 
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T2* (TR 1764 ms, TE 25ms, voxel 0.24x0.24x1 mm). No specific correction or post-
processing techniques were used.  
The region of interest (ROI) was determined by semiological data and by localization 
of epileptiform abnormalities recorded during MEG, projected on a 3D T1 3T MRI.  
 
Images were visually assessed by two experienced neuroradiologists and one 
neurologist specialized in epilepsy. The first assessment was done by these 3 
specialists independently of each other, while taking semiologic data into account but 
without knowledge of the MEG-results. A second assessment was based on visual 
guidance by MEG. Presence and location of MRI abnormalities were noted and 
compared to the contralateral site. Finally conclusions by the individual specialists 
were compared. To establish the level of concordance the generalized or Fleiss 
kappa was calculated.  
In this study, one patient in whom an SEEG recording (Munari et al 1994) was 
performed before, and five patients in whom an SEEG recording was performed after 
the 7T MRI were included. In one patient intracranial recording using multiple 
subdural strips was carried out. Results of the intracranial recordings and results of 
surgery, when performed, were not available at the time of analysis of the MRI. 
However, surgical outcome and histological diagnosis were added in a later stage to 
the database in patients who underwent resective surgery. For patients without 
abnormalities on the first analysis of 7T MRI but a successful resection, two of the 
three observers re-evaluated the 7T MRI. 
The medical ethical committee of LUMC approved the study protocol. All patients 
provided informed consent. 
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Results 
Twenty patients were studied. Complete data were obtained in 19 patients (patient 
and seizure characteristics: table 1). 13 Patients did not show any new abnormalities 
on 7T MRI as compared to 3T MRI despite MEG-guidance. Of these 13 patients, 
however, patient 7 showed abundant extensive white matter hyper-intensities, 
hampering detailed interpretation of the images. In three of the remaining six patients 
new abnormalities were seen that fitted the clinical epilepsy symptoms by all three 
observers without prior knowledge of the MEG-findings. All three showed 
characteristics of FCD type II. In retrospect, one of these three patients also showed 
discrete signs of FCD on the 3T images (supplementary data fig S1).  
     
Supplementary data Fig S1: Possible FCD after conventional visual analysis missed on 3T MRI (left), but seen on 
7T MRI (middle). On the right the post-resection image. Transversal FLAIR images. 
Further MEG-guided visual inspection of the 7T MRI data resulted in possible 
abnormalities in three more patients (fig 1). There was, however, no concordance 
among the observers in these patients as to the presence of an abnormality. 
Furthermore, no clear differential diagnosis could be given. Also, in one of the 
patients in whom semiology guided analysis showed a FCD MEG-guided analysis did 
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not point to the same location. The generalized or Fleiss kappa between the 
observers was 0.683. 
Patient gender Age Semiology 
1 F 45 Undefinable feeling, orofacial automatisms, motionless. Clusters. 
2 M 36 Abrupt hyperkinetic movements of all extremities. 
3 F 31 1) short lasting unresponsiveness and freezing 2) painful sensation stomach 3) 
clusters of staring and automatisms. 
4 M 33 Headache, orofacial automatisms , lowered consciousness, inconsistent version. 
5 M 23 Sometimes auditive aura. Gasping for breath and fast eye blinking. Late in seizure 
turning to left and lowered consciousness. Provocation by specific sounds possible 
but not mandatory 
6 F 34 Tingling left hand, cramp left hand, hyperkinesias left arm 
7 M 65 Shout, bilateralhypertonia changing to clonias. Postictal incoherent speech. 
8 M 19 Arousal, clonias both arms, head turning to right 
9 M 56 Head version to left, tonic left arm, then leg and face. Preserved consciousness 
10 F 49 Arms hyperkinetic, vocalisation, inadequate responses 
11 M 29 Tingling right hand, cramp right hand 
12 M 27 1) Sensations left arm, than leg, then lowered consciousness and automatisms 2) 
cramps left arm, secondary generalisation 
13 M 32 Feeling warm, dreamy, cramps hands, orofacial automatisms, inability to react, 
lowered consciousness, fists, stretching arms. Mainly during sleep. 
14 F  Strange feeling stomach, feeling of falling through the floor, inability to react 
15 F 21 Head version to right, tonic right hemi face 
16 M 46 Right arm turns backward while trembling.  
17 F 33 1) No grip on her own thoughts 2) clonic movements eyes (sometimes also head) 
to the right. 
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18 M 19 1) up to 30s lowered conscience 2) nausea, loss of conscience, peri-oral cramps, 
making sounds, turning away eyes.  
19 F 28 1) fear, turning red, incontinence. 2) Asymmetric cramp arms (L>R), torso flexed, 
tachypneu, followed by restlessness and manual automatisms 
20 M 32 Pre-ictal hyperactive behaviour, then staring, perspiring, lowered conscience, 
restlessness. Sometimes leading to spastic movements, clonias, foaming mouth, 
hitting and kicking, tongue bite, grey skin.  
Table 1: patient characteristics: gender, age, present semiology. 
 
  
Fig 1: left: Discrete possible abnormality only seen after MEG guidance. Clinical representation (patients left is on the right of the 
image) 
Right: representation on MRI of 5 MEG spikes. Attention: Physicist’s representation (patients left is on the left of the image). 
 
In the six patients with (possible) abnormalities on the 7T MRI perfect concordance 
was found between 7T MRI abnormality and regional location and lateralisation as 
predicted on clinical grounds. In other words: in these patients, the abnormality found 
with MRI was localized well within the clinically predicted region. In two patients MEG 
dipole localizations showed perfect concordance with the MRI abnormality. In three 
patients MEG dipoles and 7T MRI abnormalities were within each others vicinity but 
not exactly overlapping. In one patient MEG pointed at an area far away from the 
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abnormalities seen on 7T MRI. Other investigations, when present, gave mixed 
results (table 2). 
patient clinic V-EEG PET SPECT NPT SEEG MEG 7T MRI 
1 T/F R>L F/T R/L T R/L F/T - - RO, LT NA 
2 LF F - - - - L F NA 
3 F/P/T/I R R C-P - - Network, R PTO R C-P 
R T 
NA 
4 T/F R T - - R R T (amygdala) R T NA 
5 R TPO/I R F/T/I R T - - - R T-P  ?R I 
6 R F-C Extra-T R F/T - diffuse R F R F R F 
7 F - - - - - L T Multiple 
8 L F L P-O L T  L - L T (F) NA  
9 
 
R R F-C - - - R F R P R F 
10 F R F - P NA - R F 
L T 
R F (old) 
11 
 
L F/P-C - - - - - L C L C 
12 R 
F/P/C/I 
R T/C-P/I R P - NA - R P NA 
13 F/T/othe
rs 
- - - - - L T NA 
14 
 
P/I/F/T L T L T L F NA L F L C L F ? 
(n=1/3) 
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16 L C L>R C L I - NA L F (post 
cingulum) 
L C NA 
17 L F L>R F NA LF NA - L F L F? 
18 F F L T - (R) F Strips: not on 
focus.  bilateral 
F and O? 
R F/T 
(associate-
analysis:   L 
P/O) 
NA 
19 F/I F/O/I NA - - - L F NA 
20 F/T/I (R) F/T/P NA - - - L T NA 
 
Table 2: concordance between localization based on clinical data, V-EEG, SEEG, PET, SPECT, MEG, NPT 
(neuropsychological testing) and 7T MRI (final conclusion). R: right, L: left, C: central, F: frontal, I: insular, O: 
occipital, P: parietal, S: parasaggital, T: temporal, TPO: Temporo-parieto-occipital junction, PA: histopathologic 
diagnosis, -: Not Available.  NA: No Abnormalities. ?: no concordance between all 3 observers. Patient 15 did not 
complete the MRI and is therefor not listed in this table. 
 
In one patient the location of the identified abnormality on 7T MRI influenced the 
decision not to proceed with presurgical analysis. In five patients MRI information 
was helpful in proposing an SEEG (n=2) and/or surgical planning, leading to 
resection in three. This resulted in seizure freedom for two patients and marked 
seizure reduction in one patient, whereas two patients refrained from continuing 
presurgical analysis.  
Intracranial recordings to prove location of the epileptogenic focus were performed in 
eight out of the 19 patients: seven patients were analysed with implantation of 
multiple intracerebral electrodes (SEEG) and one patient with arrays of subdural 
strips (table 3). Due to the used neurosurgical approaches histopathologic diagnosis 
could not be obtained in all patients. Two of the SEEG implantations were performed 
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in patients with a FCD unanimously detected on 7T MRI. Both were operated upon, 
histopathology showed FCD type II. In one of these two patients SEEG was 
performed before the 7T MRI was made. Some of the trajectories of the removed 
electrodes were still visible (Supplementary Data fig S2).  
 
Supplementary Data Fig S2: traces of depth electrodes that were removed 5 weeks before (pat 9) 
 
MEG predicted a right posterior frontal focus, whereas SEEG showed the focus to be 
more anterior frontal. Subsequent 7T MRI showed possible abnormalities located 
antero-basal to the most anterior SEEG electrode. The resected area included both 
the SEEG region and the abnormal region on 7T MRI. One SEEG implantation was 
performed in a patient with an electrode within the area that was suspicious based on 
the 7T MRI. (fig 2). Histopathologic diagnosis could not be obtained. 
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patient 7T MRI ICR histopathology Outcome 
3 NA SEEG: network R Not available Not operated 
4 NA SEEG: RT NA 34 mo seizure free 
6 RF SEEG: RF FCD IIb 46 mo seizure free 
8 NA SEEG: multifocal Not available Not operated 
9 RF SEEG: RF FCD IIa? (quality of the 
material obtained was 
insufficient to make a firm 
statement) 
27 mo seizure free 
14 LF? SEEG: LF Not available 16 mo seizure free, then 
recurrence. Frequency and 
severity of the seizures are 
markedly less than before 
operation. 
16 NA SEEG: LF FCD II? (quality of the 
material obtained was 
insufficient to make a firm 
statement) 
15 mo seizure free 
18 NA Strips: bilateral F/O, 
onset not recorded 
Not available Not operated 
 
Table 3: data of patients that underwent intracranial recording (ICR). FCD: Focal Cortical Dysplasia, F/O: Frontal 
to Occipital, LF: Left Frontal, mo: months, NA: No Abnormalities, R: Right, RF: right frontal, RT: Right Temporal, 
SEEG: stereo-EEG/multiple depth electrodes 
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Fig 2: Left: 1.5T MRI with SEEG in situ. Top: contacts  LC 1-4 encircled. Bottom: contacts LX 4-6 encircled. Right: bipolar SEEG 
traces  at the beginning of a seizure. Seizure onset with high amplitude wave followed by gamma-activity on contacts LC 2-3 
(left anterior cingulum) and contacts LX 4-5 (left anterior insula). Contacts LC 2-3 correspond with highlighted 
Of the five patients with an undisputed normal MRI undergoing intracranial 
recordings, one patient had a clear-cut seizure onset zone demonstrated by SEEG in 
the posterior bank of the left cingulate gyrus. The electrical properties of the region as 
well as the local ictal SEEG pattern and the post-operative histopathology suggested 
the presence of FCD. Re-analysis of the 7T MRI still did not show any abnormalities 
in this region (fig 3). Resection resulted in seizure freedom. 
One patient with signs of FCD in the left central region decided not to proceed with 
epilepsy surgery due to fear of complications. 
   
   
Fig 3: Re-evaluated region of epileptic focus as proved by SEEG that before SEEG were considered to be without anatomical 
abnormalities on visual inspection of the 7T MRI 
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Structural abnormalities that were believed to be unrelated to the epileptic seizures 
were described in five patients both on 3T and 7T MRI: once multiple 
hyperintensities, once traumatic lesions far anterior to the suspected epileptic focus 
but in the same right medial frontal gyrus, twice arachnoid cysts and SEEG post-
implantation abnormalities in one patient.  
In one patient examination was interrupted due to restlessness during the imaging 
session. One of the patients experienced several habitual short-lasting seizures of 
lowered consciousness and peculiar sensations without motor signs during the 
scanning, not intervening with the scanning procedure.  No other adverse events 
were noted during MRI-examination.  
 
Discussion 
This study analysed semiology- and MEG-guided 7T MRI in patients with epilepsy in 
whom visual MEG-assisted 3T MRI analysis did not show abnormalities that could 
explain the epilepsy. In 3 out of 19 patients, a formerly unnoticed lesion with 
characteristics of an FCD was found. In 3 other patients the observers were not 
unanimous with regard to the visual analysis. In one of these, by using SEEG the 
possible abnormality proved to be the epileptogenic focus. In the other 2 patients 
there was no functional (SEEG) or histopathological proof available on the possible 
abnormalities as seen on the 7T MRI. Therefor, it is not possible to conclude whether 
the findings could have been of clinical importance in these 2 patients. However, 
detection of these abnormalities can influence the decision making process during 
pre-surgical evaluation, making it more likely that the patient is not (yet) rejected for 
epilepsy surgery. Therefor, this finding is of clinical importance. 
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This study was performed in a highly selected group of patients; all but one of the 
patients were undergoing pre-surgical analysis. Therefor, the level of confidence on 
the accuracy of the diagnosis of diagnosis of localization related epilepsy was high. 
The additional gain of 7T MRI compared to 3T MRI has clinical importance for this 
specific patient group. However, results of this study cannot easily be translated to a 
more general group of patients with epilepsy. 
Recently, a comparable study was published on the detectability of FCD’s on 7T MRI 
in 21 patients without definite lesions on 3T or 1.5T MRI, showing a 29% diagnostic 
gain (De Ciantis et al 2016). Agreement in imaging interpretation was reached 
through consensus-based discussions based on visual identification of structural 
abnormalities. Four out of the 6 patients with a thus detected lesion were operated, 
all showing FCD on histopathology. These results are almost identical to our own 
results, even without additional guidance by a pre-determined ROI. However, in 50% 
of their patients with an abnormality on 7T MRI a dubious region was already 
mentioned on visual inspection of lower field strength MRI. In our cohort even after 
re-examination of the lower field strength MRI’s with knowledge of the outcome at 7T 
MRI in only 1 out of 6 cases a lesion could be detected on previous scans. In contrast 
to the study by De Ciantis et al, in our cohort all patients previously had a 3T MRI, 
which in each individual was inspected after MEG-results were available. Therefor, 
our inclusion criteria were much more vigorous. The above leads us to postulate that 
MEG-guided 7T MRI has higher additional value than 7T MRI sec. Also, the used 
sequences, although being of the same type, differed in scan-parameters. Without 
head-to-head comparison between the two protocols in the same patients we cannot 
estimate differences in additional value.   
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Earlier work on 7T MRI in refractory temporal lobe epilepsy (Henry et al 2011, Coras 
et al 2014, Derix 2014) showed the possibility to measure hippocampal subregions 
and border variability. Further analysis of 7T MRI along the lines of the study by Henri 
might provide even more additional value of 7T MRI in patients with suspicion of 
temporal lobe epilepsy. 
 
In our study, using conventional visual analysis 7T MRI showed additional 
abnormalities even in the ¾ of patients in whom MAP07 of 3T MRI did not indicate 
abnormalities, with over-all abnormalities in up to 32% of 3T MRI negative patients. 
Voxel based morphology analysis of 7T MRI is under investigation (Seiger et al 
2015). 
Our study population is too small to define the definite number needed to diagnose 
for 7T MRI. However, comparison with literature on other modalities, mostly used in 
presurgical analysis, can help to give an indication of the relative benefit of the use of 
7T MRI in this patient group.    
For example, 1H-MRS (Magnetic Resonance Spectroscopy) is helpful in lateralisation 
of the abnormal temporal lobe in all patients with MRI-negative temporal lobe 
epilepsy (Xu et al  2015) as well as extra-temporal epilepsies (Colon et al 2010). 
MRS is much less helpful in localizing the epileptogenic focus in the abnormal 
hemisphere as MRS highlights network metabolic dysfunction rather than the 
epileptogenic focus (Pan et al 2012). The abnormalities found in our study also 
provide a clear cut localization, making 7T MRI more suitable for presurgical analysis 
than MRS.  
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For SPECT (Single Photon Emission Computed Tomography) sensitivity rates are 
reported to be ranging from 81% to 90% (Spencer 1994) for ictal SPECT. However, 
SPECT is performed in very selected cases and success is highly dependent on 
early ictal injection (Desai et al 2013). Due to the low temporal resolution, SPECT 
often highlights both the ictal onset zone and the propagation pathways 
(VanPaesschen et al 2007). Removal of an area with concordance between 
intracranial recording and SPECT leads to seizure freedom in only 66.7% of cases 
(Schneider et al 2013). These findings support the notion of SPECT as a marker of 
the epileptic network, whereas abnormalities on 7T MRI are more likely to represent 
the epileptogenic focus.  
PET (Positron Emission Tomography) is mainly used in MRI negative patients, 
depicting metabolic activity of the brain. Especially in temporal lobe epilepsy a 
unilobar PET hypo metabolism is highly predictive of a good outcome (Yang et al 
2014). However, PET tends to show more (sub)lobar hypo metabolism, rather than 
localised abnormalities (Komoto et al 2015). In current clinical practise, PET will only 
be applied if MRI does not give sufficient information.  
Comparing 7T MRI to the modalities mentioned above, it has a potential additional 
role in pre-surgical analysis of epilepsy patients. In our study MEG guidance had 
added value when scoring the 7T MRI as compared to semiology alone as in three 
out of the six abnormal MRI’s the abnormality was not detected based on semiology 
alone without MEG-guidance.  
MEG abnormalities are described with FCD (Wilenius et al 2013) and can be used in 
daily practise (Colon et al 2016). In our cohort in five out of 19 patients 7T MRI 
abnormalities were found in concordance with MEG at the level of lobe and 
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lateralisation. However, in three of these 7T MRI and MEG localizations were not 
100% overlapping. In one additional patient with MRI features of a FCD, MEG even 
seemed to be falsely localizing. This might reflect the intrinsic limitation of MEG 
analysis, being based upon determining the source of a signal using a mathematical 
model, trying to explain the recorded signal given a certain number of assumptions 
and limitations (Baillet 2001, Grave de Peralta 2009); the inverse problem (Helmholtz 
1847). There are reports of convexity source localization errors of up to 2 cm using 
MEG (Sutherling et al 2001). In our patients some sources were located in deeper 
structures, making it likely that localization errors can even be larger (Hillebrand 
2002). Another explanation could be that deeper sources can become visible on 
MEG after propagation of the activity to more superficial regions, thus highlighting 
this region instead of the epileptogenic focus. Last but not least, MEG records 
interictal epileptiform activity. This activity is an indication of the irritative zone, but  
does not necessarily reflects the epileptogenic zone. 
High field MRI provides much more detailed images than 3T MRI. Some normal 
variants, as for example occipital extending ventricular walls, can be mistaken for 
FCD (Supplementary data, fig S3). On the other hand the discordance between MEG 
and MRI might point to false positive findings at 7T MRI. This might be true for the 
three out of six possible abnormalities found where there was no concordance 
among the observers. However, SEEG showed one out of these three to be the 
epileptogenic focus. In both other cases neither SEEG nor surgery has been 
performed. In case SEEG would have been planned, using the information gained by 
7T MRI as well as by MEG would probably have impacted the implantation strategy. 
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Supplementary Data fig S3: occipital normal variant mimicking FCD 
 
Use of the clinical MEG report, in combination with a representation of the MEG 
sources projected on MRI in three planes, sufficiently guides the eye of the 
radiologist. However, visual inspection of a 7T MRI without concordance with clinical 
signs and symptoms may lead to erroneous conclusions. Therefor we advocate that 
on request of 7T MRI epileptologists should  incorporate clinical data and possible 
spreading patterns of epileptic activity including hypotheses on possible location in 
order to help the radiologists in their analysis and thus enable them to be clinical 
neuroradiologists in the true sense of the word. E.g. in our series there was 1 patient 
in whom semiology pointed towards a temporal epileptogenic focus but MEG 
indicated an occipital focus. This reflects a known spreading pattern and is therefor 
not incongruent. In this case MRI must thoroughly be inspected in the occipital 
regions. 
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Conclusion: 
 Semiology-guided visual analysis of 7T MRI has by itself already demonstrated a 
marking of possible epileptogenic abnormalities resembling FCD that were formerly 
not detected on MEG guided 3T MRI in 3 out of 19 of our patients. In an additional 3 
out of 19 patients adding MEG-guidance lead to the detection of a possible lesion on 
7T MRI. This is of clinical importance and especially in the pre-surgical work-up a 
valuable addition to current protocols. 
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CHAPTER 5 
Synopsis 
5.1 Summary 
Epilepsy is one of the most frequent neurologic disorders, characterized by the 
occurrence of multiple unprovoked epileptic seizures (fits). If drug treatment is 
ineffective epilepsy surgery can be a good alternative. 
To ameliorate diagnostics in epilepsy is an ungoing quest. Both in first line, e.i. 
diagnosing epilepsy, as in localizing the epileptogenic zone in case of presurgical 
analysis. The studies in this thesis examine possible roles for MEG and MRI in 
improving diagnostics in epilepsy, both alone and in combination. 
 
The two studies in chapter 3 evaluate the possible role of MEG as primary 
diagnosticum for epilepsy. At present, history, semiology and EEG are the basis for 
diagnosis, often supplemented with MRI. If a routine EEG is insufficient to make a 
definite diagnosis, an EEG after sleep deprivation is asked for. This is a rather patient 
unfriendly procedure, in contrast to MEG. Chapter 3.1 describes a prospective study 
on diagnostic gain of MEG in 51 patients in whom routine EEG showed no 
abnormalities. A methodology to apply MEG as stand-alone investigation in daily 
practice is developed. Basis for analysis is final clinical diagnosis and conclusion of 
the report, NOT  individual spike-hunting. The results are retrospectively compared to 
semiology and to outcome of EEG after sleep deprivation. No major differences are 
found between MEG and EEG after sleep deprivation, although there is a slight trend 
in favor of MEG showing a gain in diagnostic value of 63%.  
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As there is no literature proving that an original MEG or EEG conclusion is predictive 
of the diagnosis on the long run, chapter 3.2 describes the consistency over time of 
the diagnosis and its correlation with the original MEG and EEG after sleep 
deprivation. Information of 46 patients out of the 51 from the first study could be 
retrieved 8 years later, making it possible to examine the robustness of the original 
conclusion as compared to the last clinical diagnosis. In 8 of the 46 patients 
diagnosis changed. Both for MEG and for EEG after sleep deprivation the long-term 
correlation with the diagnosis diminished, for MEG from 63% to 61% and for EEG 
after sleep deprivation from 57% to 50%. Remarkably, spikes tend to be more 
predictive than sharp waves, albeit numbers are too small to make a firm statement 
on this observation. More specific to the positive results, sensitivity of sharp 
phenomena (combining spikes and sharp waves) in routine MEG and in EEG-SD for 
the long-term (3–8 years) diagnosis epilepsy is 71% and 62%, respectively.  
 
Chapter 4 describes possible roles of MRS and of 7T MRI, partly based on previous 
MEG findings. Chapter 4.1 describes single voxel 1H-MRS in 19 patients, 10 with a 
known temporal FCD and 9 otherwise 3T MRI negative patients with temporal lobe 
epilepsy seeking for confirmation of the MEG-based hypothesis of lateralisation of 
epileptogenic zone. Relative concentrations of measured metabolites are calculated 
per voxel and compared to outcome in a mirror-voxel on the opposite side. In both 
groups NAA/Cr ratio is significantly lower on the affected side whereas the results for 
Cho/Cr ratios are more diverse. There are no significant differences between the two 
groups, making single voxel 1H-MRS a reliable predictor of lateralisation in case of 
an MRI-negative epilepsy patient. 
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Chapter 4.2.1 describes the appearance on 7T MRI of lesions already seen at lower 
field strength. This study is a preparation for chapter 4.2.2. Ten patients in whom 
previously a probable FCD was diagnosed on 1.5T (n=1) or 3T (n=9) MRI undergo a 
7T MRI. The MRI characteristics of FCD are visually evaluated by three specialists, 
comparison between 3T and 7T images are made and radiologic diagnosis is 
compared to histopathology in the 5 cases where this is available. In 2 out of 10 
patients the original diagnosis of FCD is changed. Image quality at 7T MRI is 
significantly higher than the quality at 3T MRI. At 7T, FLAIR turns out to be the 
sequence in which the abnormality is easiest detected, T2 and T2* are better suited 
to review structure and extent of the lesion, whereas T1-weighted images highlight 
cortical thickening and blurring most prominent. A hypo-intense line at the grey-white 
matter junction is striking on T2 weighted images creating a typical three layer flag-
like appearance. 
Chapter 4.2.2 describes findings of MEG-guided 7T MRI in a cohort of 19 patients 
with localization related epilepsy in whom a MEG-guided state-of-the-art 3T MRI did 
not reveal a structural lesion. This is the first publication on epilepsy patients 
undergoing MEG-guided 7T MRI in whom former MEG-guided 3T MRI analysis 
reported no abnormalities. In those cases where it is available other data from pre-
surgical analysis and post-resection histopathology are compared to findings at 
MEG-guided 7T MRI. Three specialists visually analyse the 7T images. New 
abnormalities are detected by all three observers in 3 patients. Retrospectively, in 
one of these patients the abnormality was already visible on 3T MRI, but not in the 
other 2. Not unanimous, there are indications for another abnormality in 3 more 
patients, one of which is proven by depth recordings to be the epileptogenic focus. 
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The MRI of another patient with a focus found with depth recordings, showing a 
classical FCD-signal, stayed unremarkable at re-evaluation. 
Findings are compared with the gain in MRI-negative patients of voxel based 
morphology, MRS, SPECT, and PET. This leads to the observation that MEG-guided 
7T MRI provides a valuable added gain in pre-surgical analysis. 
Concluding, MEG is a robust and reliable diagnosticum, not just in diagnosing 
epilepsy but also in guiding analysis of MRS and of 7T MRI. MRS in itself can 
indicate the lateralisation of an epileptogenic zone. Further, abnormalities are better 
(to anyway) visible on 7T MRI than on lower field strengths. Especially if the review is 
MEG-guided, making MEG-guided 7T MRI a welcome addition to the test possibilities 
in the pre-surgical analysis of patients with a refractory localization related epilepsy.  
 
5.2 Samenvatting (dutch version of summary) 
Epilepsie is een van de meest frequent voorkomende neurologische aandoeningen 
en wordt gekenmerkt door het spontaan optreden van meerdere epileptische 
aanvallen (toevallen). Als medicatie niet werkt kan epilepsie chirurgie een goed 
alternatief zijn.  
Het is een voortdurende queeste om de diagnostiek voor epilepsie te verbeteren. 
Zowel initieel, oftewel bij het vaststellen dat er sprake is van epilepsie, als ook bij het 
lokaliseren van de epileptogene zone in geval van pre-chirurgische analyse. De 
onderzoeken in dit proefschrift onderzoeken of MEG en MRI mogelijk een rol kunnen 
spelen in de verbetering van de diagnostiek bij epilepsie, zowel losstaand als in 
combinatie. 
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De twee onderzoeken in hoofdstuk 3 evalueren de mogelijke rol van MEG als eerste 
lijns diagnosticum voor epilepsie. Momenteel is het zo dat voorgeschiedenis, 
semiologie en EEG de basis vormen voor de diagnostiek, vaak aangevuld met MRI. 
Als een routine EEG onvoldoende is om tot een definitieve diagnose te komen wordt 
vaak een EEG na slaapdeprivatie aangevraagd. Dit is een nogal patiënt-
onvriendelijke methode, in tegenstelling tot MEG. Hoofdstuk 3.1 beschrijft een  
prospectief onderzoek naar de diagnostische opbrengst van MEG bij  51 patiënten 
waarbij routine EEG geen afwijkingen toonde. Een methode om MEG als losstaand 
onderzoek in de dagelijkse praktijk toe te kunnen passen is ontwikkeld. Analyse van 
de data is gebaseerd op het niveau van diagnose en conclusie in het verslag, NIET 
op het niveau van individuele pieken. De uitkomsten zijn retrospectief vergeleken met 
de semiologie en met de uitkomst van het EEG na slaapdeprivatie. Er zijn geen 
overweldigende verschillen gevonden tussen MEG en EEG na slaapdeprivatie, al 
bestaat er wel een trend ten faveure van MEG, waar een winst in diagnostische 
waarde van 63% wordt gevonden.  
Aangezien er geen literatuur gevonden is die aantoont dat de uitkomst van een MEG 
of EEG voorspellend is voor de diagnose op langere termijn beschrijft hoofdstuk 3.2 
de consistentie over de tijd van een gestelde diagnose en de relatie hiervan met de 
oorspronkelijke uitslag van MEG en EEG na slaapdeprivatie. Acht jaar na het eerste 
onderzoek kunnen gegevens over 46 van de oorspronkelijke 51 patiënten boven 
water gehaald worden, waarmee de consistentie van de originele conclusie 
vergeleken kan worden met de laatst beschikbare klinische diagnose. Bij 8 van de 46 
patiënten veranderde de diagnosis. Bij zowel MEG als bij EEG na slaapdeprivatie 
verminderde op lange termijn de overeenkomst met de diagnose, voor MEG van 63% 
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naar 61% en voor EEG na slaapdeprivatie van 57% naar 50%. Opvallenderwijs lijken 
pieken een betere voorspeller van de definitieve prognose dan scherpe golven, al is 
de groep te klein om over deze observatie een harde uitspaak te kunnen doen. Meer 
toegespitst op de positieve uitslagen, gevoeligheid van scherpe fenomenen (pieken 
en scherpe golven bij elkaar genomen) in routine MEG en in EEG na slaapdeprivatie 
voor de diagnose epilepsie bedraagt op de langere termijn (3–8 jaren) respectievelijk 
71% en 62%.  
 
Hoofdstuk 4 beschrijft mogelijke rollen voor MRS en voor 7T MRI, gedeeltelijk 
gebaseerd op eerdere MEG-bevindingen. Hoofdstuk 4.1 beschrijft single voxel 1H-
MRS in 19 patiënten, 10 bekend met een temporale FCD en 9 verder 3T MRI 
negatieve patiënten met temporaalkwab epilepsie waarbij gezocht wordt naar 
bevestiging van een op MEG-gebaseerde hypothese aangaande de  lateralisatie van 
de mogelijke epileptogene zone. Relatieve concentraties van de gemeten 
metabolieten worden per voxel berekend en vergeleken met de uitkomsten vanuit 
een spiegel-voxel contralateraal. In beide groepen blijkt de NAA/Cr ratio significant 
lager aan de aangedane zijde, terwijl de uitkomsten voor Cho/Cr ratio veel diverser 
zijn. Er zijn geen significante verschillen tussen beide groepen en single voxel 1H-
MRS is een betrouwbare voorspeller van lateralisatie, ook bij MRI-negatieve 
epilepsie patiënten. 
Hoofdstuk 4.2.1 beschrijft het voorkomen op 7T MRI van bekende lesies die al op 
lagere veldsterkte zijn aangetoond. Deze studie dient als voorbereiding voor 
hoofdstuk 4.2.2. Tien patiënten bij wie in eerdere fase een FCD was vastgesteld, 
gebaseerd op 1.5T (n=1) of 3T (n=9) MRI ondergaan een 7T MRI. De MRI 
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karakteristieken van FCD worden door 3 specialisten visueel beoordeeld, een 
vergelijking tussen de 3T en de 7T beelden wordt gemaakt en de radiologische 
diagnose wordt vergeleken met de histopathologie in de 5 gevallen dat deze 
beschikbaar is. In 2 van de 10 patiënten verandert de oorspronkelijke diagnose FCD. 
Beeldkwaliteit is bij 7T significant hoger dan bij 3T. Bij 7T blijkt FLAIR de sequentie te 
zijn waarmee een afwijking het makkelijkst gezien wordt, T2 en T2* zijn geschikter 
om de structuur en uitgebreidheid van het afwijkende gebied te bekijken, terwijl T1-
gewogen beelden corticale verdikking en vervaging van de wit/grijze stof demarcatie 
goed zichtbaar maken. Een hypo-intense lijn ter hoogte van de overgang van witte 
naar grijze stof valt vooral op op T2 gewogen beelden, aldus een typische 3-banen 
vlag-achtig beeld tonend. 
Hoofdstuk 4.2.2 beschrijft bevindingen bij MEG-gestuurde 7T MRI in een cohort van 
19 patiënten met localisatie gerelateerde epilepsie waarbij eerdere MEG-gestuurde 
state-of-the-art 3T MRI geen structurele lesie aan het licht bracht. Dit is de eerste 
publicatie over daadwerkelijke 3T MRI negatieve epilepsie patiënten die een MEG-
gestuurde 7T MRI analyse ondergaan. Daar waar beschikbaar worden de 
bevindingen vergeleken met overige data uit de pre-chirurgische analyse en post-
operatieve histopathologie. Drie specialisten voeren een visuele analyse van de 7T 
beelden uit. Alle 3 zijn ze het eens over nieuwe afwijkingen bij 3 patiënten. 
Terugkijkend was bij 1 van deze patiënten de afwijking al zichtbaar op de 3T MRI, 
maar niet bij de andere 2. Daarnaast zijn er bij nog 3 patiënten aanwijzingen voor 
afwijkingen die echter niet door alle 3 de specialisten gezien worden. Bij 1 hiervan 
toont een diepteregistratie aan dat dit ook het epileptogene focus is. De MRI van een 
andere patiënt waarbij diepteregistratie een focus aantoont met een klassieke FCD 
signatuur blijft ook bij herbeoordeling brandschoon.  
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De uitkomsten worden vergeleken met de opbrengsten van voxel based morphology, 
MRS, SPECT en PET bij MRI-negatieve patiënten. Dit leidt tot de observatie dat 
MEG-gestuurde 7T MRI een waardevolle aanvullende waarde heeft in de pre-
chirurgische analyse. 
Tot besluit kan worden gesteld dat MEG een robuust en betrouwbaar diagnosticum 
is, niet alleen ter vaststelling van epilepsie maar ook als richtingaanwijzer voor MRS 
en 7T MRI. MRS kan op zich al aanwijzingen geven over lateralisatie van een 
epileptogene zone. Verder zijn afwijkingen beter (tot überhaupt) zichtbaar op 7T MRI 
dan op lagere veldsterktes, vooral als er MEG-gestuurd naar de plaatjes gekeken 
wordt. Hiermee is 7T MRI een welkome aanvulling op het onderzoekspallet in pre-
chirurgische analyse bij patiënten met een refractaire localisatiegebonden epilepsie. 
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CHAPTER 6 
General discussion and future perspectives 
 
The studies in this thesis were all concerned with questions on how diagnostic 
procedures in epilepsy can be improved. To that aim, possibilities and reliability of 
MEG, MRS and 7T MRI were explored, each showing specific advantages and 
disadvantages, both as stand alone investigation as in combination with each other. 
This is in line with experiences in daily practice of epilepsy and of epilepsy surgery: 
no investigation provides the answer in all patients and in (almost) no patient all 
investigations are positive. This might also be one of the reasons why there is no 
uniformity in the used methodology in presurgical evaluation amongst different 
experienced centers (Mouthaan 2016). The results of the studies presented here, 
however, have several implications. 
First, MEG and EEG-SD have shown to be good predictors of the diagnosis of 
epilepsy if epileptiform activity was present in the encephalography. Interestingly, in 
contrast to the debates the past decades, the notion that in EEG spikes and sharp 
waves are equally strong markers for the diagnosis of epilepsy was not completely 
endorsed. In the upcoming years for both modalities we will enlarge the cohort in 
order to evaluate whether this observation should lead to a repraisal of the impact of 
spikes versus sharp waves in diagnosing epilepsy. Furthermore, routine MEG tended 
to be at least as sensitive as EEG-SD, which is in line with the evaluation of gain of 
MEG and EEG in a population of patients that underwent earlier EEG’s without 
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epileptiform abnormalities as reported by Duez et al (2016). They describe an added 
value of MEG to EEG of 14 to 18%, which is even higher than our findings of 11% 
added value. The next step is to examine if MEG could replace EEG-SD plus routine 
EEG in the first-line diagnostic procedures. To answer that question we started a 
study based on the model of chapter 3.1, comparing conclusions of MEG, routine 
EEG and EEG-SD reports to the clinical diagnosis at the end of the diagnostic 
process. Furthermore, a medical technology assessment is carried out to evaluate 
practical and financial feasibility of implementing MEG in daily practice in the dutch 
setting. This will not only be based on gain from a medical and patient point of view, 
but also on cost-effectiveness. After all, almost every european hospital owns EEG-
equipment but at present access to MEG is very limited. Furthermore, for MEG both 
costs of purchase and maintenance (e.g. costs of liquid helium) are higher than for 
EEG. On the other hand, whether costs of personnel are higher for EEG or for MEG 
is not clear yet. Although analysis time is much longer for MEG as compared to EEG,  
preparation and cleaning time are much shorter. Finally, in contrast to EEG, for MEG 
no additional equipment (such as caps or contact paste) is necessary.  
A second advantage of implementing MEG early in the diagnostic process could be 
that IF a patient is refractory and becomes a possible candidate for epilepsy surgery, 
data to execute MSI are already present. De Tiege et al (2012) showed that MEG 
influences desicion making in the pre-surgical analysis when available during the final 
stage. However, at present it is unclear at what stage of the pre-surgical analysis the 
impact of this data could be highest. Therefor, a study has started comparing intra-
individually the different impacts on decisions when MEG data become available in 
different phases of this process.  
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MRS seemed quite promising when the study started. It held the promise of being 
able to demonstrate focal metabolic abnormalities indicating the epileptogenic zone. 
As it turned out in recent years, MRS is a good lateralizer but is much less helpful in 
localizing the epileptogenic zone in the abnormal hemisphere as MRS highlights 
network metabolic dysfunction rather than the epileptogenic zone (Pan 2012). 
Therefor, MRS changes reflect changes in the epileptic network, much less of the 
epileptogenic zone. This zone is the holy grail of epilepsy surgery. After our first 
enthousiasm, in our center MRS tended to disappear into oblivion. As in several 
patients with temporal lobe epilepsy lateralisation is more of a problem than 
localization, based on our own research MRS deserves to be revitalized. 
Nevertheless, results should be met with caution: we presumed a lateralisation index 
to be correct if the results were concordant with visible abnormalities (FCD on MRI) 
and/or with physiological tests (MEG). This implies the risk of circular reasoning. 
Correlation with intracranial recordings and with outcome after surgery was not yet 
established. Furthermore, in patients with bilateral temporal lobe epilepsy there still 
could be an asymmetry, giving rise to a misleading lateralisation index. Finding an 
asymmetry should therefor urge the investigator to re-examine the original data.  
During the last years there is some emerging evidence that finding a lesion on MRI is 
NOT the prognostic factor par excellence for success of epilepsy surgery, as success 
rates of resections in non-lesional cases can in highly selected cases be up to 88% 
as well (Chen 2016, Ryvlin 2014, Chassoux 2012, Hyslop 2012, Lee 2011). 
Unfortunately, to reach this success percentage in these cases very extensive pre-
surgical workup is necessary. Therefor, the role of MRI remains highly important. 7T 
MRI is becoming more easily available, with more 7T machines installed every year. 
Seen the results presented in the literature this year and in this thesis, there is 
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definitely a place for 7T MRI in epilepsy diagnostics. During the 12-th European 
Congress on epileptology, September 2016, Prague, the group of Veersema 
presented their experiences with 7T MRI in formerly MRI-negative epilepsy surgery 
candidates. They described 8 lesions in 38 patients in whom former MRI was 
considered normal. Histopathology was not (yet) available for all 8 cases. This is in 
line with our findings of 6 abnormalities in 19 patients when adding localizing 
information based on a MEG-guided ROI. It is likely that the combination of 7T MRI 
with an adequately defined ROI will lead to improvement of outcome of epilepsy 
surgery or giving access to epilepsy surgery to more patients. To define the ROI, 
MEG can be helpful, as was shown in our study. However, MEG is not the only 
modality capable of indicating a reasonable ROI. Other modalities can indicate the 
ROI as well. Therefor, we extended our inclusion and started a 7T MRI study where 
all 3T MRI negative patients within the epilepsy surgery program in whom a robust 
and plausible hypothesis on location of the seizure onset zone can be formulated will 
be included. With time, this will also lead to more tissue specimens being available 
and more correlations being made between pathology and MRI findings. This, in turn, 
will lead to better understanding of the images themselves. 
With the new ILAE proposal for “Terminology and concepts for organization of 
seizures and epilepsies” a more holistic approach of patients with epilepsy emerges.  
Integrating more different investigative modalities to analyse a patient fits this 
development. Finally, Hippocrates was right: “It is more important to know what kind 
of person has this disease than to know what kind of disease this person has”.
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 Dankwoord 
Het is gebruikelijk om in een dankwoord een vaste volgorde aan te houden, met als alpha en 
omega de twee belangrijkste steunpilaren van de promotie: de promotor en het eigen gezin. 
Binnen een promotie vanuit de setting waarin ik aan dit proefschrift gewerkt heb is 
ondersteuning vanuit mijn gezin echter alpha en omega. Op de voet gevolgd door mijn 
promotie-team. En ook verder doet de standaard volgorde mijns inziens geen recht aan de 
input en ondersteuning van al die anderen die vaak ook bijzonder belangrijk geweest zijn: de 
patiënten, andere begeleiders van binnen ACE en daarbuiten die af en toe de belangrijkste 
sparring partners waren, de onmisbare secretaresses en bibliothecaresses, de opleiders die 
mij gevormd hebben en last but not least de naaste collegae. Helaas, het is ondoenlijk om 
iedereen op de eerste plaats te noemen. En een ex aequo is te ingewikkeld. De mores zijn er 
niet voor niets, dus is deze dankzegging in de bijna gebruikelijke volgorde. De lijst is te lang 
om iedereen te kunnen noemen zonder een extra boek uit te geven. Tot mijn spijt dus 
slechts een –bijna willekeurige- selectie: 
 
Aan de patiënten die hun medewerking aan de onderzoeken hebben gegeven: uw bijdrage 
was volledig belangeloos. Sterker nog, u heeft tijd noch moeite gespaard om de 
onderzoeken beschreven in dit proefschrift mogelijk te maken. Ik hoop uw vertrouwen 
waardig te zijn geweest en met deze onderzoeken en vooral ook de onderzoeken die hier 
nog uit voort komen een bijdrage te kunnen leveren aan verbeteringen van de zorg voor 
epilepsiepatiënten.  
Geachte professor Boon, beste Paul, 
Zonder uw duwtjes in de juiste richting op de juiste momenten zou dit proefschrift er nooit 
gekomen zijn. Dit was al zo nog voor de officiële start van het promotie-traject. De introductie 
van het SEEG in Nederland voelde voor mij al als een proeve van bekwaamheid. En tijdens 
het promotietraject waren er ook meerdere momenten dat dagelijkse werkzaamheden een 
promotietraject dreigden onder te sneeuwen. Uw sturing op deze momenten was onmisbaar. 
Gelukkig zonder acute momenten. 
Maar het meest heb ik misschien nog wel geleerd van je eindeloos positieve instelling, je 
vermogen om schijnbaar onoplosbare situaties tot een oplossing te brengen zonder ook 
maar één van de kemphanen het gevoel te geven miskend te worden. En het was heerlijk 
om een bourgondische levensinslag te delen. Ik hoop nog vele malen de dis met je te mogen 
delen. 
 
Geachte professor Hofman, Beste Paul, 
De rol van co-promotor kan niet worden overschat. Uw rol in de aanvang met de 
samenwerking met het LUMC, evenals in de afronding van de MRI-gerelateerde onderdelen 
van dit proefschrift kan niet anders dan als essentieel omschreven worden.  
160 
 
Het komt vast niet vaak voor dat een copromotor tijdens een promotietraject zelf tot 
hoogleraar promoveert. Dat je ondanks deze ontwikkeling tijd hield om je ook op persoonlijk 
vlak te blijven interesseren voor de voortgang van mijn promotietraject heb ik zeer op prijs 
gesteld. Je heldere (en soms voor mij onorthodoxe) visies gaven vaak een andere kijk op 
moeilijke situaties. Zowel inhoudelijk als ook organisatorisch.  
 
Geachte dr Ossenblok, Beste Pauly, 
Het leeuwendeel van de “dagelijkse” begeleiding van mijn promotietraject kwam op uw 
schouders neer. U bent geen makkelijke tante, en daar heb ik van genoten. Gelukkig is de 
digitale tijd aangebroken, anders zou ik u ondertussen een dozijn rode stiften schuldig zijn.  
De afgelopen jaren heeft onze samenwerking zich geïntensiveerd en zijn er vele projecten 
waarbij jij mij ook betrokken hebt. Deze samenwerking mag wat mij betreft nog heel lang 
duren! Het is altijd weer een genoegen “ even”  de tijd te nemen om nieuwe stappen te 
bespreken. Maar ook om “even” te roddelen over hoe de hazen lopen. En daar op de 
achtergrond de visie van Han in door te horen klinken. Jammer dat hij er nu niet meer bij kan 
zijn.  
 
Esteemed members of the examination and reading board, prof dr M. Cools, Prof. dr P. 
Ryvlin, Prof. dr C. Dirven, Prof. dr E. Achten, Prof. dr D. Van Roost, Prof. dr K. Vonck and dr 
M. Vlooswijk, thank you for the time and effort you have put in reading and evaluating this 
thesis. Your valued comments made this booklet quite presentable. 
 
Geachte dr Van Osch, Beste Thijs, 
Wat was het interessant om via dit proefschrift de cultuurverschillen tussen de verschillende 
universiteiten van nabij mee te mogen maken. Vanuit LUMC was jij degene die het 
frequentst en het uitgebreidst reageerde. Ik hou van Socratiaans discussiëren, maar jij wist 
mij soms tot wanhoop te drijven. Na alles te laten bezinken waren al jouw commentaren 
echter altijd weer zinvol en grond voor verbetering. Ik beschouw jou voor een deel van deze 
promotie als een co-copromotor en wil jou in het bijzonder danken voor de energie die jij 
hierin gestoken hebt. 
 
Geachte professor Stam, 
Zeker in de beginfase van dit proefschrift heeft u veel invloed gehad op de opzet van zowel 
het MEG-onderzoek als hoe MEG als indicator voor een ROI gebruikt kan worden. Uw 
invloed is groter geweest dan de frequentie waarin uw naam in de auteurslijsten voorkomt 
doet vermoeden. Wat mij betreft ligt de oorzaak hiervan in uw bescheidenheid. Ik hoop van 
harte in de toekomst nog vaker met u de degens te mogen kruisen voor een 
vriendschappelijke trainingswedstrijd.  
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Geachte dr Ter Beek, beste Leon 
Het MRS-onderzoek was niet mogelijk geweest zonder jouw enthousiasme. In 
Kempenhaeghe was weinig ervaring met MRI en met deze techniek op het moment dat onze 
3T MRI geplaatst werd. In mijn herinnering hebben we samen veel problemen getackled. 
Maar tegelijkertijd ben ik ervan overtuigd dat dat een gefabriceerde herinnering is en dat jij 
het leeuwendeel van de oplossingen voor je rekening genomen hebt. 
 
Beste Mathijs Buijs, 
Dank voor je eindeloos geduld en flexibiliteit in het plannen en registreren van 
epilepsiepatiënten op de 7T MRI van het Gortercentrum. Het had niets met jouw eigen 
promotietraject te maken, en ook persoonlijk kenden we elkaar nog niet. Veel succes met 
jouw boekje. En met pokeren. 
 
Geachte professor Van Buchem, 
De ruimte die u mij in het LUMC geboden heeft, gecombineerd met uw pragmatisme zijn van 
onschatbare waarde geweest. Het is verre van eenvoudig om een proefschrift te schrijven 
waarbij meerdere universiteiten en instituten betrokken zijn wat geleid heeft tot veel pushen 
van mijn kant. En af en toe wat wisselende standpunten. U heeft dat lijdzaam én leidzaam in 
goede banen geleid. Ik wens u het allerbeste met “uw” afdeling. 
 
Geachte dr Van der Grond, 
Communicatie met u was altijd aangenaam, leuk zelfs. Het feit dat er na officieus overleg 
met u vaak ineens zaken mogelijk bleken die daarvoor moeilijk te realiseren waren doet mij 
vermoeden dat uw invloed groter is geweest dan u liet blijken. Dank. 
 
Geachte Drs. Wagner, beste Louis, 
Geen enkel onderzoek hier beschreven, geen enkele stap van het promotietraject is zonder 
jouw welkome commentaar, en nog welkomere steun geweest. We hebben een goed 
epilepsie-chirurgieteam. Nu is het jouw beurt. Ik hoop dat de moeilijkheden die ik ben 
tegengekomen jou niet ontmoedigd hebben, en dat de dag van de promotie zelf jou 
inspireert. En ik hoop jouw proces van nabij mee te mogen maken. Succes! 
 
Geachte professor De Louw, Beste Anton, 
Jouw initiatief om de arts-promovendi van ACE Kempenhaeghe “schrijfweken” toe te kennen 
is het laatste zetje geweest dat noodzakelijk was om tot een afronding te kunnen komen. En 
ook jij hebt achter de schermen zonder twijfel meer gedaan dan zichtbaar is.  
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Geachte Ir Bomer en Mw De Ruijter, 
Dank, dat jullie binnen Kempenhaeghe de situatie hebben gecreëerd waarbinnen promotie 
mogelijk was. Het is boekhoudkundig vast niet altijd de beste optie. Jullie visie is gelukkig 
breder dan dat. 
 
Geachte dr Geurts en dr Chatroux, 
Dank dat jullie in het post-Ike tijdperk de ruimte voor promotie gecontinueerd hebben. En 
versterkt. Het waren roerige tijden, en die zijn nog niet voorbij.  
 
Beste Saskia en Daniëlle, 
Jullie gingen mij voor, waarmee ik mij nu de laatste van de drie musketiers voel. Het was fijn 
om de laatste jaren een grotere verbondenheid te voelen. Ik was niet alleen. Tijd voor een 
feestje! 
 
Beste collegae in Kempenhaeghe, 
Jullie hebben veel opgevangen. Zonder klagen en zonder mopperen. Ik had mij geen 
aangenamere collegae kunnen wensen. 
 
Beste laboranten (ja Remco, ook jij!), observanten, onderzoeksverpleegkundigen en 
verpleegkundigen, 
Jullie hebben mijn leven een stuk minder stressvol gemaakt de afgelopen jaren. Jullie steun 
en begrip (en de glaasjes sinaasappelsap, waarvoor speciale dank aan Elly) maakten het 
dragelijk. Hoe heerlijk om af en toe stoom af te kunnen blazen! Ik prijs mij gelukkig met zo’n 
“familie”. Harrie, als eerste SEEG sparring partner, mag zeker niet onvermeld blijven, maar 
ook Petra die mee aan de wieg heeft gestaan van mijn eerste onderzoek niet. 
 
Beste Irene, 
Een bibliothecaresse die sneller antwoordt dan haar schaduw is de droom van iedere 
promovendus. Ik had er zo een. Hoe je het doet is mij nog steeds een raadsel. Dat je het 
voor elkaar krijgt een wonder dat ik dankbaar aanschouwd heb. Nog leuker was dat je het 
altijd met een glimlach voor elkaar kreeg. Ik hoop nog lang met je te mogen samenwerken. 
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Beste Aleida en Linda, 
Jullie hebben enkele jaren als secretaresse mijn leven aangenamer weten te maken. Niets 
ten nadele van de rest, maar jullie zijn twee van de vier beste secretaresses van 
Kempenhaeghe. Dank voor jullie steun en flexibiliteit.  
 
Beste Ivanka, 
Jij bent nummer drie. Een stabiel KNF-secretariaat waar meer informatie te halen valt dan 
volgens de taak-functie-omschrijving verwacht kan worden. Volgens mij hebben zowel jij als 
ik daar lol in en van. Hopelijk zijn we nog niet van elkaar af. 
 
Beste Ine, 
Jij bent de vierde die ik hierboven nog niet genoemd had. Zonder jou en jouw aansturing zou 
het ONMOGELIJK geweest zijn om het epilepsiechirurgie traject in Kempenhaeghe te 
draaien EN te promoveren. Soms ben ik ervan overtuigd dat jij nog meer uren werkt dan ik. 
Waarom lukt het me maar niet jou op tijd naar huis te sturen? 
 
Geachte dr B. Hylkema, 
U beseft het waarschijnlijk niet, want ik heb het u nog nooit verteld. Mijn tijd op de intensive 
care in Enschede onder uw begeleiding heeft mijn attitude enorm gevormd. Zelden heb ik 
zo’n fraaie combinatie van menselijkheid en wetenschappelijke interesse mogen 
aanschouwen. Ik hoop er wat van opgestoken te hebben. In ieder geval heeft het zeker 
bijgedragen aan mijn attitude en daarmee aan het voltooien van dit proefschrift. 
 
Geachte dr Franke, beste Cees, 
Het was een bijzondere opleiding. Dank dat ik de ruimte kreeg mijn eigen idealen na te 
steven en voor de ondersteuning in het vinden van een opleidingsplek hoofdvakker Klinische 
neurofysiologie. Deze deelopleiding in Kempenhaeghe heeft me geen windeieren gelegd. 
Jouw wijze van probleem oplossen ben ik gaandeweg het promotietraject steeds meer gaan 
waarderen. 
 
Geachte dr Vredeveld, beste Jan-Willem, 
Wat moet ik hier nou schrijven? Dat jij een goed klankbord geweest bent voor de KNF? Dat 
we enkele zeer fraaie plexus-onderzoeken gedaan hebben? Dat het net zo goed een plexus-
promotie had kunnen worden, ware ik niet naar Kempenhaeghe gegaan? Dat ik het samen 
koken mis maar nog meer jouw maaltijden? Het is altijd een onderdrijving van de 
werkelijkheid. Dank voor een goede, spannende en inspirerende tijd. 
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Geachte professor Arends, beste Johan, 
Vanaf mijn eerste schreden in Kempenhaeghe tot en met de laatste schreden voor afronding 
van dit proefschrift mocht ik uw steun ervaren. Zelden ben ik zo’n altijd positieve stimulator 
tegengekomen, en ik verwacht ook niet er ooit nog een te kunnen vinden. Rancune is je 
vreemd, energie is je tweede naam. Het is onvoorstelbaar dat ook jij ooit met pensioen zult 
gaan. 
 
Beste Ellen, geachte dr Veltman, 
Bij sommige mensen weet ik gewoon niet waar ik moet beginnen en wil ik eigenlijk niet 
eindigen. En ergens in het verhaal wil ik Viktor eigenlijk ook nog noemen. Lange lunch doen? 
 
Beste Olaf, Beste Olthof, 
België kent geen paranimphen. In de geest zijn jullie dat voor mij wel. Dat zegt eigenlijk alles. 
 
LUMC, VUmc, MUMC+, uzGent en Kempenhaeghe, 
De vijf instituten die een actieve rol hebben gespeeld in mijn promotie-periode. Het is niet 
makkelijk geweest. En niet snel. Wel leerzaam. Ik ben dankbaar dat al deze instituten de 
ruimte hebben geboden om deze promovendus die niet helemaal binnen de regeltjes paste 
zijn weg te laten vinden.  
 
Beste Lynn, 
Zonder jou was ik nooit wegwijs geworden. Zeker in de laatste fase was jouw steun mijn 
lichtpuntje in de ondoorgrondelijke duisternis van de Vlaamse regelgeving. Dank. 
 
Dear Heather, 
So nice to have a neighbour that not only is a very pleasant and sofisticated person but also 
a native English speaker willing to help correct the most ridiculous mistakes. Time for a good 
glas of wine! 
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Beste Jan, 
Met je schoonvader discusiëren over zo iets kleins als quarks en magnetisch moment… Wat 
kunnen we toch pietluttig zijn. Heerlijk. 
 
Beste Emma, 
Weinig promovendi zullen een eerste engelse correctie door hun pete-nicht kunnen laten 
doen. Het was enorm boeiend om dit proces mee te maken. Ik kijk ernaar uit jou ook als 
collega te mogen groeten. 
 
Beste Gongers, Lamawaaiers, buurtgenoten, vrienden en familie, 
Zelden zullen zoveel mensen zo vaak het excuus van “ geen tijd, moet promoveren”  
gehoord hebben. Ik voelde me meer dan gesteund en vooral ook geaccepteerd. Waar jullie 
geduld vandaan komt weet ik niet, maar het heeft me wel door de moeilijkste tijden heen 
geholpen. Mijn waardering voor jullie is gigantisch. 
 
Oerol, Parade, Sonsbeek-festival, etcetera, enzovoorts, 
Het leven is meer dan de alledaagse bezigheden. De bijzondere momenten zijn onderdeel 
van het evenwicht, zonder welke een promovendus autistisch wordt. Nederland kent vele 
opties, waarvan ik dankbaar gebruik gemaakt heb.  
 
Lieve zus, 
Jaja, het komt er echt van. Tijd om een andere running gag te gaan verzinnen. 
 
Lieve ouders, 
Alle ups en downs hebben jullie meegemaakt. Wonderlijke trajecten. Himmelhoch jauchtzend 
zum toden betrubt was het net niet, maar het zat er wel eens tegenaan. Zonder jullie steun 
en opvoeding en opvang en Calonge en enz, enz, enz betwijfel ik of dit proefschrift er was 
gekomen. Ik ben trots dit moment met jullie te mogen delen. 
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Lieve Laurien en Maarten, 
Dit proefschrift draag ik aan jullie op. Bij tijd en wijle was dit proefschrift de reden dat jullie 
een minder aanwezige vader hadden. Jullie hebben er nooit over geklaagd. Sterker nog, 
jullie stimuleerden mij zo nu en dan als ik er even helemaal doorheen zat. Dank. 
 
Ruscha, lieve Ruscha 
Van ons allemaal heb jij het het zwaarst gehad. En heb jij het minst geklaagd. Niet over het 
feit dat ik veel buitenshuis was, niet over het feit dat ik thuis veel achter de computer zat, 
nauwelijks over het feit dat ik vaak moe was. Hoe je het hebt volgehouden is mij een raadsel, 
zeker met je eigen opleiding tot psychotherapeut er de laatste jaren naast. Eerder afgerond 
dan ik mijn promotie... In opvoeding en regelen van zaken vormen wij een prima team, maar 
belangrijker nog is de liefde die wij delen. We gaan er ook verder een mooie tijd van maken 
samen! 
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